CD4 T Cell Interaction with Intestinal Microbes under Homeostasis and Inflammation by Chai, Jiani
Washington University in St. Louis
Washington University Open Scholarship
Arts & Sciences Electronic Theses and Dissertations Arts & Sciences
Summer 8-15-2018
CD4 T Cell Interaction with Intestinal Microbes
under Homeostasis and Inflammation
Jiani Chai
Washington University in St. Louis
Follow this and additional works at: https://openscholarship.wustl.edu/art_sci_etds
Part of the Allergy and Immunology Commons, Immunology and Infectious Disease Commons,
and the Medical Immunology Commons
This Dissertation is brought to you for free and open access by the Arts & Sciences at Washington University Open Scholarship. It has been accepted
for inclusion in Arts & Sciences Electronic Theses and Dissertations by an authorized administrator of Washington University Open Scholarship. For
more information, please contact digital@wumail.wustl.edu.
Recommended Citation
Chai, Jiani, "CD4 T Cell Interaction with Intestinal Microbes under Homeostasis and Inflammation" (2018). Arts & Sciences Electronic
Theses and Dissertations. 1613.
https://openscholarship.wustl.edu/art_sci_etds/1613
  
WASHINGTON UNIVERSITY IN ST. LOUIS 
Division of Biology and Biomedical Sciences 
Immunology 
 
Dissertation Examination Committee: 
Chyi-Song Hsieh, Chair  
Paul Allen 
Marco Colonna 
Takeshi Egawa 
Thaddeus Stappenbeck 
 
 
 
CD4 T Cell Interaction with Intestinal Microbes under Homeostasis and Inflammation 
by 
Jiani Chai 
 
 
A dissertation presented to  
The Graduate School  
of Washington University in  
partial fulfillment of the  
requirements for the degree  
of Doctor of Philosophy 
 
 
August 2018 
St. Louis, Missouri 
  
 
 
 
 
 
 
 
 
 
 
 
 
© 2018, Jiani Chai
ii 
 
Table of Contents 
List of Figures ........................................................................................................................................................ iii 
List of Tables .......................................................................................................................................................... iv 
List of Abbreviations ............................................................................................................................................ v 
Acknowledgments .............................................................................................................................................. vii 
Abstract of the dissertation.................................................................................................................................. ix 
Chapter 1: Introduction ...................................................................................................................................... 1 
Chapter 2: Helicobacter species induce pTreg cell differentiation during homeostasis ......... 14 
2.1 Abstract ...................................................................................................................................................... 14 
2.2 Introduction ............................................................................................................................................. 15 
2.3 Materials and Methods ........................................................................................................................ 18 
2.4 Results ........................................................................................................................................................ 24 
2.5 Discussion ................................................................................................................................................. 28 
2.6 Figures ........................................................................................................................................................ 30 
Chapter 3: Characterization of T cell response to gut microbes in inflammation .................... 41 
3.1 Abstract ...................................................................................................................................................... 41 
3.2 Introduction ............................................................................................................................................. 42 
3.3 Materials and Methods ........................................................................................................................ 44 
3.4 Results ........................................................................................................................................................ 53 
3.5 Discussion ................................................................................................................................................. 60 
3.6 Figures ........................................................................................................................................................ 63 
3.7 Tables .......................................................................................................................................................... 85 
Chapter 4: Concluding Remarks and Future Directions ...................................................................... 88 
References ............................................................................................................................................................. 91 
iii 
 
List of Figures 
Figure 2.1 Colonic Treg TCRs react to mucosal-associated Helicobacter species. .................... 31 
Figure 2.2 Reactivity of colonic Treg TCRs to mucosal-associated Helicobacter species is 
MHCII dependent. .............................................................................................................................................. 32 
Figure 2.3 CT2/CT6/CT9/T7-1 TCRs do not react to other bacterial isolates tested. ............ 35 
Figure 2.4 Helicobacter species induce peripheral Treg cell differentiation during 
homeostasis. ......................................................................................................................................................... 37 
Figure 2.5 Gating strategy and confirmation of Helicobacter spp. inoculation in Figure 2.4B.
 ................................................................................................................................................................................... 39 
Figure 2.6 Relative expansion of pTregs in Helicobacter-colonized mice. ................................... 40 
Figure 3.1 Colonic Treg TCRs (CT2 and CT6) drive effector T cell development in 
inflammation. ....................................................................................................................................................... 63 
Figure 3.2 DSS+IL10R treatment induces colitis and effector T cell responses. .................... 66 
Figure 3.3 Effects of DSS+IL10R-mediated colitis on the TCR repertoire. ................................ 68 
Figure 3.4 Treg and Teff subsets show increased TCR overlap during colitis. ........................... 70 
Figure 3.5 CBir1 TCR Tg cells become Teff, and not Treg, cells during DSS+IL10R colitis. 71 
Figure 3.6 DSS+αIL10R colitis is associated with differential changes of bacterial 
composition in the lumen and mucosa. ..................................................................................................... 74 
Figure 3.7 Quantification of 16S rRNA gene abundance in the lumen or MA preparation.... 75 
Figure 3.8 Expansion of Bacteroides species during colitis does not enhance TCR-specific T 
cell responses. ..................................................................................................................................................... 76 
Figure 3.9 Specificity of DP1/NT2/CT7 TCRs for Bacteroides spp. ................................................ 78 
Figure 3.10 Pathogenic potential of naive Helicobacter-reactive CT6 cells in lymphopenic 
mice. ........................................................................................................................................................................ 79 
Figure 3.11 Bacterial-specific induction of colitis by CT2 in lymphopenic mice. ...................... 81 
Figure 3.12 Helicobacter spp are detected in fecal and colonoscopy samples from IBD 
patients. ................................................................................................................................................................. 83 
 
iv 
 
List of Tables 
Table 3.1 TRAV Multiplex primer sequences. .......................................................................................... 86 
Table 3.2 TRAV designation, CDR3 amino acid (a.a.) sequences, and in vitro bacterial 
reactivity of indicated TCR clones. .............................................................................................................. 87 
 
 
 
 
  
v 
 
List of Abbreviations 
 
Altered Schaedler flora (ASF) 
Antigen-presenting cells (APCs)  
Anti-IL-10R antibody (αIL10R) 
Bacteroides (B.) 
Brain-heart-infusion (BHI) 
Cell Trace Violet (CTV) 
Colon lamina propria (cLP) 
Conserved noncoding sequence-1 (CNS-1) 
Crohn’s disease (CD)  
Dendritic cells (DCs) 
Dextran sodium sulfate (DSS) 
Distal mesenteric lymph node (dMLN) 
Effector T (Teff) cells 
Fluorescence-activated cell sorting (FACS) 
Germ-free (GF) 
Helicobacter (H.)  
Inflammatory bowel disease (IBD) 
Myeloid differentiation primary response gene 88 (MyD88) 
Mucosal-associated (MA) 
Neuropilin-1 (Nrp-1) 
Operational Taxonomic Units (OTUs) 
Phosphate-buffered saline (PBS) 
Polysaccharide A (PSA) 
vi 
 
Regulatory T (Treg) cells 
Retinal dehydrogenase (RALDH) 
Retinoic acid (RA) 
Ribosomal RNA (rRNA) 
Segmented filamentous bacteria (SFB) 
Short-chain fatty acids (SCFAs) 
Specific-pathogen-free (SPF) 
T cell receptor (TCR) 
TCR alpha joining (TRAJ) 
TCR alpha variable (TRAV)  
Toll-like receptors (TLRs) 
Toxoplasma gondii (T. gondii) 
Transgenic (Tg) 
Ubiquitin-like, with pleckstrin-homology and RING-finger domains 1 (Uhrf1) 
Ulcerative colitis (UC)  
vii 
 
Acknowledgments 
 
 
I would first like to thank my mentor, Chyi Hsieh, for his guidance throughout 
my time in graduate school. He trained me to think independently, to design 
experiments to test hypothesis, to troubleshoot and find alternative solutions, and 
to interpret and present data, all of which are important for me to become an 
independent researcher. I greatly appreciate his patience and enthusiasm in 
teaching, as well as the unique resources in his lab for me to pursue interesting 
scientific questions.   
 
I would also like to thank the Hsieh lab members, both present and past. Every 
one of them has helped me, either through direct technical help or through sharing 
ideas. I greatly appreciate their support, and would not have enjoyed graduate 
school nearly as much without their company. 
 
I would additionally like to thank our collaborators who made this work 
possible by sharing their expertise and knowledge, especially the Fox, Stappenbeck, 
Kau, and Newberry labs.  
 
Many thanks are also due to my thesis committee members. They offered very 
thoughtful advice and questions that helped to make this work better. They also 
gave their time and advice outside of committee meetings whenever I had questions.  
 
viii 
 
Last, but not least, I would like to thank my friends and family. I am grateful for 
their love and support. I wound not be able to finish this whole journey without 
them.  
 
Jiani Chai 
Washington University in St. Louis 
August 2018 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ix 
 
 
ABSTRACT OF THE DISSERTATION 
CD4 T Cell Interaction with Intestinal Microbes under Homeostasis and Inflammation 
by 
Jiani Chai 
Doctor of Philosophy in Biology and Biomedical Sciences 
Immunology 
Washington University in St. Louis, 2018 
Professor Chyi-Song Hsieh, Chair  
 
Specific gut commensal bacteria improve host health by eliciting mutualistic regulatory T 
(Treg) cells responses. However, the bacteria that induce effector T (Teff) cells during 
inflammation are unclear. Here, we addressed this by analyzing bacterial-reactive T cell receptor 
(TCR) transgenic cells and TCR repertoires in a murine colitis model. Unexpectedly, we found 
that mucosal-associated Helicobacter species triggered both Treg responses during homeostasis 
and Teff responses during colitis, as suggested by an increased overlap between the Teff/Treg 
TCR repertoires with colitis. In fact, 4/6 Treg TCRs tested recognized mucosal-associated 
Helicobacter species in vitro and in vivo. By contrast, the marked expansion of luminal 
Bacteroides species seen during colitis did not trigger a commensurate Teff response. Unlike other 
Treg cell-inducing bacteria, Helicobacter species are known pathobionts and cause disease in 
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immunodeficient mice. Thus, our study suggests a model in which mucosal bacteria elicit 
context-dependent Treg or effector cell responses to facilitate intestinal tolerance or 
inflammation. 
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Chapter 1: Introduction 
 
 Trillions of commensal bacteria cohabit our bodies to mutual benefit. In the past several 
years, it has become clear that the adaptive immune system is not ignorant of intestinal 
commensal bacteria, but is constantly interacting with them. For T cells, the response to 
commensal bacteria does not appear uniform, as certain commensal bacterial species appear to 
trigger Teff cells to reject and control them, whereas other species elicit Foxp3+ Treg cells to 
accept and be tolerant of them. However, the specificity of intestinal Treg and Teff cells, and how 
these T cells respond to gut bacteria under different microenvironment remain largely unclear. In 
this thesis, we analyzed the antigen-specificity of colonic Treg and Teff TCR repertoire in mouse 
model, identified Helicobacter-reactive TCRs, and studied the differentiation of 
bacterial-specific T cell during homeostasis and under colonic inflammation.   
 
Regulatory T cells play a crucial role in maintaining 
tolerance to commensal bacteria  
The intestines are home to hundreds of commensal bacterial species that provide many 
benefits to the host, including important contributions to the metabolism of food1. However, as 
commensal bacteria are foreign to the host, they can trigger unwanted immune responses such as 
inflammatory bowel disease (IBD)2. Yet, the gastrointestinal tract is also an important portal for 
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bacterial infections. Thus, the immune system must protect against pathogenic bacteria while 
avoiding inappropriate immune responses to commensal bacteria.   
Although the mucosal lining of the intestine provides an important protective barrier 
against commensal bacteria, it has become clear that this barrier is imperfect, resulting in a need 
for immune tolerance to gut antigens. One of the first clues came from early studies showing that 
a subset of CD4+ T cells3, now known to be Foxp3+ Treg cells, is required to prevent other CD4+ 
T cells from inducing colitis upon transfer into lymphopenic hosts (reviewed in 4,5). Subsequent 
studies showed that commensal bacteria are important for driving intestinal pathology in the 
context of Treg cell deficiency. For example, ablation of IL-2 leads to a loss of Treg cell number 
and function, which results in a variety of immunopathology6. However, only colitis is markedly 
reduced in germ-free (GF) IL-2-deficient mice7–9. Similarly, GF conditions limit colitis, but not 
other inflammatory manifestations, that arise with depletion of Foxp3+ cells in Foxp3DTR mice10, 
or with T cell deletion of Uhrf1 (Ubiquitin-like, with pleckstrin-homology and RING-finger 
domains 1), an epigenetic regulator that facilitates colonic Treg proliferation and maturation11. 
As memory T cells from conventionally housed mice are more efficient at inducing colitis12, 
these data suggest that Treg cells act to restrain normal effector responses to commensal bacteria. 
Thus, Treg cells are important in establishing a tolerogenic environment to maintain immune 
homeostasis to commensal bacteria in the intestine.  
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Substantial progress has been made in the past several years regarding the origin and 
specificity of Treg cells involved in intestinal tolerance. Although it is still debated13, several 
lines of evidence suggest that colonic Treg cells arise primarily from peripheral Treg cell 
differentiation from naïve T cells (pTreg,14,15), as opposed to arising from the thymus during T 
cell development (tTreg,16,17). First, adoptive transfer of naïve T cells into normal hosts 
suggested that the intestines are sites that facilitate peripheral Treg cell selection18. Second, 
markers that may distinguish thymic Treg cells such as high expression of Helios or Neuropilin-1 
(Nrp-1) imply that ~80% of colonic Treg cells arise from peripheral selection19–21. Third, one T 
cell receptor (TCR) repertoire study suggested that most colonic Treg TCRs do not facilitate 
thymic Treg cell selection22. Fourth, a study of Foxp3-deficient mice devoid of Treg cells 
revealed that adoptive transfer of natural Treg cells was not sufficient to restore immune 
homeostasis, and required transfer of Foxp3– cells capable of undergoing peripheral Treg cell 
selection23. Finally, studies of the Foxp3 locus revealed that mice deficient in conserved 
noncoding sequence-1 (CNS-1) had fewer Treg cells in the intestine, which was correlated with a 
defect in peripheral Treg cell selection24,25. Taken together, these data support an important role 
for peripheral Treg cell selection in the gut.  
However, other reports have argued against this interpretation. For example, the 
sensitivity and specificity of markers of thymic versus peripheral Treg cell selection such as 
Helios has been called into question26–28. Moreover, a different TCR repertoire study suggested 
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that most colonic Treg cells are of thymic origin based on cross-referencing TCR sequences29. 
While future experiments are required to determine the exact proportions of pTreg versus tTreg 
in the colon, it is clear that the intestines are enriched in pTreg cells relative to other tissues in 
the body.  
 In regards to the antigen specificity of colonic Treg cells, recent studies suggest that 
they are often reactive to commensal bacteria. First, several studies reported that some, but not 
all, bacterial species can increase the frequency of Treg cells in the gut. For example, 
Clostridium clusters XIVa and IV30,31 or altered Schaedler flora (ASF)32 introduced into GF mice 
markedly increased the frequency of colonic Treg cells. Lactobacillus reuteri 33 has also been 
associated with increased Treg cell percentage in the intestines. Second, analyses of TCR 
repertoires suggested that a substantial fraction and perhaps the majority of colonic Treg TCRs 
recognize commensal bacterial antigens. Since the TCR repertoire is extremely complex, mice 
with limited TCR repertoires were used to assess the colonic Treg TCR repertoire22,34. In these 
studies, it was observed that colonic Treg cells utilized TCRs that were different than those used 
by Treg cells in other tissues or secondary lymphoid organs22,34. Further analysis of colonic Treg 
TCRs revealed direct recognition of antigens present in colonic contents, or in several cases, 
individual bacterial isolates22,34. Consistent with TCR recognition of commensal bacterial 
antigens, antibiotic treatment could markedly change the colonic Treg repertoire34, Taken 
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together, this body of evidence strongly suggests that commensal bacteria routinely trigger 
antigen specific Treg cell responses.  
 
Effector cell generation to commensal bacteria  
Despite the plethora of intestinal factors that favor Treg cell differentiation or expansion, 
Treg cells represent only 20-40% of CD4+ T cells in the colon. Effector cells therefore represent 
the dominant T cell population within the intestine during homeostasis35,36. The generation of 
effecter T cell subsets in the intestine has been associated with signals derived from commensal 
bacteria, as GF mice harbor fewer Th1 and Th17 cells compared to conventionally housed 
mice12,37. Also, DNA from gut bacteria plays an important role in the induction of gut resident 
Th1 and Th17 cells at steady state through the engagement of TLR938. Thus, the generation of 
intestinal effector T cell population is clearly influenced by the commensal bacteria.  
It is less clear, however, whether intestinal effector T cells recognize commensal bacterial 
antigens. Indirect support comes from the observation that effector T cells induced in the 
presence of commensal bacteria are more efficient at inducing colitis than cells from GF mice12. 
However, this does not necessarily mean that effector cells are specific to commensal bacteria, as 
bacterial products may also cause antigen-non-specific changes in the environment that affect T 
cell trafficking, differentiation, and function. Direct support for commensal-specific effector cell 
generation comes from murine studies of Th17 cells, which were shown to be critically 
6 
 
dependent on a single bacterial species–segmented filamentous bacteria (SFB)39. SFB is a 
spore-forming Gram-positive anaerobe residing primarily in the terminal ileum that makes 
intimate interaction with the mucosal barrier through tight attachments to epithelial cells. This 
interaction is a unique feature of SFB compared with other commensal bacteria that may underlie 
its ability to elicit Th17 cells. Recently, it was shown that the majority of Th17 cells are specific 
to SFB antigens40,41, suggesting that SFB provides both the dominant T cell epitopes as well as 
signals that facilitate Th17 differentiation. Thus, both Treg and effector cells can be elicited to 
commensal bacteria.    
 
Effector versus regulatory T cell selection 
The induction of both Treg and effector cells by commensal bacteria raises a fundamental 
question as to how the immune system determines Treg versus effector cell selection to bacterial 
antigens. Available data suggests that this is not a stochastic process, but may be instructed by 
specific bacterial species. For example, Th17 selection to SFB is not accompanied by Treg 
selection, as SFB-specific TCR transgenic cells become mostly RORt+ and not Foxp3+ cells40. 
Similarly, it has been reported that CD44hi effector T cells utilize different TCRs than Treg cells22, 
indicating cell-fate determination based on TCR specificity.   
The usage of different TCRs between Treg and effector cells could suggest that a 
biophysical property of TCR interaction with peptide:MHC, such as affinity or the amount of 
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antigen, may determine peripheral T cell selection42,43. In addition, recent studies indicate that 
environmental factors contribute to peripheral T cell differentiation to commensal bacteria. For 
example, SFB-specific TCR transgenic cells undergo Th1, and not Th17, development when 
their cognate antigen is expressed by Listeria and not SFB40. Moreover, TCR transgenic cells 
specific for the commensal CBir1 flagellin antigen adopt a Th1 phenotype upon infection with 
Toxoplasma gondii (T. gondii), but a Th17 phenotype after dextran sodium sulfate (DSS) injury44. 
Although studies of Treg versus effector cell differentiation to commensal bacteria are currently 
unavailable, OT-II TCR transgenic cells undergo peripheral Treg cell development in response to 
oral feeding of cognate antigen18,45, whereas they undergo effector cell generation in the context 
of infection46. Therefore, TCR affinity for antigen, antigen dose, and the cytokine milieu may all 
contribute to the signals that direct T cell lineage commitment.  
Innate stimulators from commensal bacteria may direct T cell differentiation via selective 
activation of cytokine production from antigen-presenting cells (APCs) by Toll-like receptors 
(TLRs), which are important sensors that recognize conserved molecular motifs on bacteria. 
TLRs have been suggested to promote pro-inflammatory effector responses. For instance, mice 
deficient in MyD88 (Myeloid differentiation primary response gene 88), an important signaling 
component for many TLRs, are relatively resistant to intestinal inflammation resulting from Treg 
cell47 or IL-1048 deficiency. Consistent with these observations, TLR9 sensing of commensal 
DNA has been suggested to favor intestinal effector (Th1/Th17) rather than Treg development49. 
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However, a role for TLRs in Treg selection has also been suggested. TLR2 signaling has been 
reported to induce IL-10 and RA to promote Treg cell selection50. DNA of the probiotic 
Lactobacillus species is enriched in suppressive motifs that signal through TLR9 to prevent 
dendritic cell (DC) activation and maintain Treg-cell conversion during inflammation51. 
Moreover, Bacteroides fragilis (B. fragilis) polysaccharide A (PSA) can trigger TLR2 signaling 
on Treg cells to induce IL-10 expression and promote tolerance52. One explanation for some of 
these contrasting reports is that TLRs are found on many cell types and contribute to facets of 
intestinal homeostasis not directly related to T cell differentiation signals, including epithelial 
integrity53. Thus, while it is likely that TLRs play an important role in T cell responses to 
commensal bacteria, their precise function in determining peripheral T cell differentiation to 
specific bacterial species remains to be determined.  
 APC subsets have also been implicated in Treg versus effecter cell determination54,55. 
Lamina propria DC subsets may provide different cytokine environments that favor Treg versus 
Th17 selection. As discussed above, CD103+ DCs have been suggested to favor Treg cell 
selection via production of retinoic acid (RA) and transforming growth factor β (TGFβ). 
Interestingly, the CD11b+ subset of CD103+ DCs have been found to be potent producers of IL-6 
and IL-23 that favor Th17 differentiation49,58,59. Consistent with these observations, genetic 
depletion of the CD103+CD11b+ DC subset showed a decrease in Th17 cells59–61, whereas 
depletion of both CD11b+ and CD11b– subsets of CD103+ DCs were required to see a decrease in 
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the number of Treg cells62. However, it is unclear whether the impact on the number of Th17 
versus Treg cells is related to specific response to bacteria species or global effects on the overall 
cytokine environment, as the decreased number of Th17 cells was independent of MHC II 
expression on the CD103+CD11b+ cells62.  
Other types of APC have also been described to be involved in gut homeostasis63. 
Macrophages, perhaps via cytokine production, can affect the regulatory to effector cell balance 
in the gut64,65. Recently, another cell type in addition to the traditional APCs (DCs and 
macrophages) has been suggested to perform an antigen presenting role in the gut. Innate 
lymphoid cells (ILCs) were recently shown to express MHC II and negatively regulate CD4+ T 
cell responses66. However, instead of inducing Treg cells, it was suggested that ILC antigen 
presentation inhibits the differentiation of effector T cells via an unknown mechanism.  
In summary, there are many parameters that can control T cell differentiation to 
commensal bacteria. There are local factors such as TLR ligands, access to mucus, and different 
APC subsets that differentially favor Treg versus effector cell selection. Moreover, it is possible 
that some global factors are also modulated at the local level, and vice versa. Anatomic factors, 
such as small intestine versus colon may also play a role by affecting the resident bacterial 
constituents (e.g. SFB is mostly ileal), mucus amount and composition, mucosal barrier function, 
and APC types. Thus, much remains to be discovered regarding how individual commensal 
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bacterial species trigger the specific mechanisms that determine Treg versus effector T cell 
differentiation.    
 
How is tolerance to commensal bacteria broken? 
For most individuals, tolerance to commensal bacteria remains intact throughout their 
lifetime. However, approximately 0.44 % of individuals break tolerance and develop IBD67. 
Genome wide association studies (GWAS) have clearly identified a number of genetic risk 
factors for IBD that affect intestinal epithelial function, general immune regulation, and innate 
immune function68,69. Defects in non-T cell related genes may increase bacterial translocation or 
outgrowth, triggering an inflammatory response from otherwise normal T cells. Defects in T cell 
related genes, such as HLA, suggest that T cell interactions with commensal bacteria may also be 
abnormal in IBD70. Thus, breakage in T cell tolerance to commensal bacteria could include a 
primary T cell defect or arise secondary to other perturbations of intestinal immune homeostasis.  
In addition to genetic factors, an intriguing question is whether environmental insults can 
break tolerance. This is suggested by the observation that IBD is increasing in geographic areas 
such as North America71. An increased risk of IBD has also been associated with recent 
gastrointestinal infections72. While commensal bacterial exposure during mucosal breaches may 
be reduced by a containment structure referred to as intraluminal cast comprised of monocytes 
and neutrophils73, intestinal infections can expose the immune system to a variety of commensal 
11 
 
bacteria74. Moreover, gut infections are associated with dysbiosis with significant shifts in 
microbiota composition. For example, -proteobacteria can become dominant due to their ability 
to thrive under inflammatory condition75,76. Thus, infection may result in the exposure to the 
immune system of previously encountered commensals as well as those that typically do not 
have access during homeostasis.  
A recent study convincingly showed that exposure of commensals to the immune system 
can occur during mucosal breaches44. They used CBir TCR transgenic T cells that recognize 
flagellin expressed by certain commensals including the Clostridium cluster XIV class of 
bacteria. Interestingly, these T cells typically possess a naïve phenotype during homeostasis, 
suggesting that they are not routinely exposed to antigen. However, barrier breach results in their 
development into Th1 cells during a highly Th1 polarizing T. gondii infection, or Th17 cells after 
DSS administration. These T cells persist long term in both the intestinal and secondary 
lymphoid tissues, and respond like memory T cells upon rechallenge. Although physical 
segregation between the microbiota and immune system is rapidly restored after resolution of 
infection, the long-term presence of commensal-specific memory T cells may fundamentally 
alter the balance of tolerance. One could speculate that over time, multiple infections may lead to 
the expansion of commensal-bacteria reactive effector T cells, potentially leading to a 
feed-forward loop in which these T cells can themselves overwhelm Treg cells and cause enough 
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inflammation to lead to barrier breach and further antigen presentation77. This could create a 
chronic and self-sustaining inflammatory state, perhaps culminating in IBD.  
And yet, intestinal infections associated with diarrhea are common and often do not 
trigger IBD78,79. Nor do other intestinal disorders such as diverticulitis or appendicitis that might 
be predicted to result in increased exposure to commensal bacteria. Perhaps the experience with 
CBir is not representative of most T cell responses during infection as its antigen is not 
constitutively presented to the immune system. Antigens that are constitutively presented may 
have already triggered the appropriate effector or regulatory T cell response. Additionally, the 
CBir antigen is flagellin, a TLR5 ligand, and may not be representative of most commensal 
bacterial ligands. Thus, it remains unclear the extent that infection or other injuries that result in 
mucosal barrier breakdown affects the balance between effector and regulatory T cell responses 
to commensal bacteria.  
 
Summary 
 Recent work has demonstrated that the adaptive immune system has continuous 
interactions with commensal bacteria to induce both regulatory and effector T cells that promote 
tolerance and immunity, respectively. The differences in the Treg versus effector cell TCR 
repertoires suggest that these T cell populations perform unique functions to maintain host health. 
However, many questions remain. What are the mechanisms by which the immune system 
13 
 
determines regulatory versus effector cell differentiation? How is this affected by infections or 
other diseases of the intestinal tract? Addressing these questions is of considerable interest to 
understanding the fundamental immunologic question of how we establish immune tolerance to 
foreign antigens, but also raises the possibility that such knowledge may be useful for the 
treatment or prevention of IBD or other allergic and autoimmune diseases of the intestines.  
14 
 
Chapter 2: Helicobacter species induce pTreg 
cell differentiation during homeostasis 
 
2.1 Abstract 
Our previous analysis of colonic Treg TCRs revealed direct recognition of antigens 
present in colonic contents. Studies using two TCR transgenic (Tg) lines that express naturally 
occurring Treg TCRs (CT2 and CT6) suggested that these bacterial antigens are continually 
presented to the adaptive immune system, as we saw continuous pTreg induction from Tg cells. 
However, specific bacterial species that elicit these T cell activations remain unknow. Here, 
using an in vitro antigen presentation system, we analyzed the reactivity of previously identified 
colonic Treg TCRs against the luminal and mucosal bacteria. Interestingly, we found that several 
of the colonic Treg TCRs are specific to Helicobacter spp., and we further confirmed that these 
Helicobacter spp. are sufficient to induce pTreg differentiation in vivo.   
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2.2 Introduction 
In the past several years, it has become clear that certain commensal bacterial species can 
elicit Treg cells which is important for maintaining gut tolerance. For example, several studies 
reported that some, but not all, bacterial species can increase the frequency of Treg cells in the 
gut. Clostridium clusters XIVa and IV30,31 or altered Schaedler flora (ASF)80 introduced into GF 
mice markedly increased the frequency of colonic Treg cells. Lactobacillus reuteri 81 has also 
been associated with increased Treg cell percentage in the intestines.  
The enhancement in peripheral Treg cell selection to commensal bacteria may result from 
a number of mechanisms. First, APC subsets in the intestine such as CD103+ DCs have been 
reported to favor Treg cell selection, as they express higher levels of retinal dehydrogenase 
(RALDH) to produce the vitamin A metabolite RA18,82,83. RA may inhibit effector cell cytokine 
production84, as well as act directly on T cells85 to promote Treg cell selection. Moreover, 
CD103+ DCs can generate TGFβ that acts in concert with RA to induce Treg cells86. Finally, it 
has been reported that these DC functions may be related to WNT/β-catenin signals that are 
delivered to intestinal, but not splenic DCs87. 
What might be the signals localized to the gut that promote these DCs to facilitate Treg 
cell selection? One recent report suggested that mucus from the intestinal lumen itself can 
activate tolerogenic pathways in DCs by triggering WNT signaling via β-catenin88. Mucus 
triggered WNT-signaling might be predicted to affect only the subset of DCs close to the 
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mucosal surface. However, a TCF reporter of WNT signaling suggests that intestinal DCs receive 
a fairly uniform degree of WNT signaling88. Future studies are required to address the relative 
contributions of mucus versus other sources of WNT signaling in intestinal DCs. 
Another potential intestinal signal for Treg cell selection may come from the microbiota 
itself. Short-chain fatty acids (SCFAs) arising from bacterial fermentation can act on DCs to 
promote tolerance89–91. SCFAs may also act directly on T cells themselves to promote colonic 
Treg cell expansion92. Another bacterial product that can affect Treg cells is PSA from B. fragilis, 
which triggers TLR2 on Treg cells to induce IL-10 production93. Thus, commensal bacteria 
themselves provide potent signals that are interpreted by the intestinal immune system to 
facilitate tolerance. 
 Less is known as regards to the antigen specificity of colonic Treg cells. Previous 
analyses of TCR repertoires suggested that a substantial fraction and perhaps the majority of 
colonic Treg TCRs recognize commensal bacterial antigens. In these studies, mice with limited 
TCR repertoires were used to assess the colonic Treg TCR repertoire22,34. It was observed that 
colonic Treg cells utilized TCRs that were different than those used by Treg cells in other tissues 
or secondary lymphoid organs22,34. Further analysis of colonic Treg TCRs revealed direct 
recognition of antigens present in colonic contents22,34. Consistent with TCR recognition of 
commensal bacterial antigens, antibiotic treatment could markedly change the colonic Treg 
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repertoire34. Therefore, these data suggest that commensal bacteria routinely trigger antigen 
specific Treg cell responses, yet more efforts are needed to identify these bacteria.  
Intestinal bacteria can be divided into two compartments based on geographic locations: 
the luminal bacteria and bacteria residing in the mucus layer. There has been evidence of 
differences between the composition of microbial communities in the outer layer of mucus of the 
large intestine and the luminal intestinal contents. Mucus consists of mucin glycoproteins sheets 
secreted by intestinal goblet cells. Only certain bacterial species have sufficient catabolic 
glycosidic enzymes to utilize mucus glycans as a sufficient carbon source94–96, therefore, the 
mucus layer can be considered as a distinct bacterial niche as compared to the luminal content. 
Indeed, a recent study showed quite interesting differences between the composition of microbial 
communities in the large intestine lumen and the mucus layer97.  
Here, using an in vitro antigen presentation system, we analyzed the reactivity of 
previously identified colonic Treg TCRs against the luminal and mucosal bacteria. Interestingly, 
we found that several of the colonic Treg TCRs are specific to Helicobacter spp. residing in the 
mucosa, and we further confirmed that these Helicobacter spp. are sufficient to induce pTreg 
differentiation in vivo.  
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2.3 Materials and Methods 
Study design 
Animal experiments were performed in an specific-pathogen-free (SPF) facility in 
accordance with the guidelines of the Institutional Animal Care and Use Committee at the 
Washington University. Host mice were housed together and interbred to maintain microbial 
integrity. Gender-matched littermate host mice were used for all comparisons. Cages were 
randomly assigned into different treatment groups. Both male and female mice were used. All in 
vivo and in vitro experiments were performed independently at least two times unless otherwise 
stated. 
 
Mice 
CT2, CT6 Tg mice22,98 were generated as described99 and bred to Rag1−/− [the Jackson 
Laboratory (JAX) #002216], Foxp3IRES-GFP (JAX #006772) or Foxp3IRES-Thy1.1 100. Foxp3IRES-Thy1.1 
mice were a gift from A. Rudensky (Memorial Sloan Kettering Cancer Center). Experiments in 
Figure 2.4B and 2.6 used Ly5.1 mice from Charles River Laboratories as hosts; all other in vivo 
experiments used Foxp3IRES-GFP CD45.1 (JAX #006772) mice. All mice were on a C57BL/6 
genetic background.  
 
Reagents, antibodies, and flow cytometry 
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Fluorescently conjugated antibodies were purchased from BioLegend, eBioscience, and 
Becton Dickinson. Samples were analyzed using a FACSAria IIu (Becton Dickinson), and data 
were processed with FlowJo (Treestar). 
 
Cell isolation from the colon lamina propria (cLP) 
Cells were isolated as described101. Colonic segments were treated with RPMI containing 
3% fetal bovine serum and 20 mM Hepes (HyClone) with dithiothreitol (DTT) (Sigma) and 
EDTA (Thermo Fisher) for 20 min at 37°C with constant stirring. Tissue was further digested 
with Liberase TL (28.3 µg/ml) (Roche) and deoxyribonuclease I (200 µg/ml) (Roche), with 
continuous stirring at 37°C for 30 min. Digested tissue was forced through a Cellector tissue 
sieve (Bellco Glass) and passed through a 40-µm cell strainer. 
 
T cell hybridoma stimulation assay 
T cell hybridoma cells expressing GFP under NFAT promoter102 were retrovirally 
transduced with TCRα chains of interest, as previously described103. Hybridoma cells (1.5 × 104) 
were cultured with flt3 ligand–elicited CD11c+ DCs (5 × 104) with and without the indicated 
antigen preparations (20 µg per well) in flat-bottomed 96-well plates. CD4+TCRα+ cells were 
analyzed for GFP expression after 1.5 days by flow cytometry. 
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Antigen preparations 
Total colonic lumen contents were collected from longitudinally opened colon and cecum, 
diluted with phosphate-buffered saline (PBS) (HyClone), vortexed, filtered through a 40-µm 
strainer, and autoclaved. For mucosal-associated (MA) antigen preparation, lumen contents were 
removed with forceps, and the remaining tissue was rinsed with PBS. MA particles were released 
from colonic tissues using PBS with DTT (1 µM/ml) and EDTA (5 µM/ml) for 20 min at 37°C 
with constant stirring, followed by PBS with EDTA (2 µM/ml) for three times. From each of 
these steps, MA particles were filtered through a 40-µm strainer. Larger particles such as cells 
were removed by centrifugation at 1500 rpm for 10 min. The remaining particles in suspension 
were pelleted at 2500 rpm for 15 min, resuspended in PBS, and then autoclaved. For bacterial 
isolates, in vitro cultures were pelleted at 2500 rpm for 15 min, washed twice with PBS, 
resuspended in PBS, and autoclaved for 45 min. 
 
Adoptive transfer experiments 
For experiments with CT2, CT6 Tg cells, Tnaïve cells were fluorescence-activated cell 
sorting (FACS)–purified (CD4+ Foxp3− CD25− CD44lo CD62Lhi) from peripheral lymph nodes 
and spleen of CD45.2 Foxp3IRES-GFP Rag1−/− TCR Tg mice. Naïve TCR Tg cells (105) were 
injected retro-orbitally into congenic CD45.1 Foxp3IRES-GFP mice. In some experiments, cells 
were first labeled with Cell Trace Violet (CTV) (Thermo Fisher) before injection. 
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For experiments using CT9, T7-1 TCR, naïve T cells (CD4+ Foxp3− CD25− CD44lo 
CD62Lhi Vα2–) were FACS purified from CD45.2 Tcli TCRαβ Foxp3IRES-Thy1.1 Tg mice (Rag1+/– 
or Rag1–/–), and activated in vitro with soluble anti-CD3 (0.1 μg/ml; 145-2C11; Bio X Cell) and 
anti-CD28 (1 μg/ml; 37.51; Bio X Cell) in tissue culture plates coated with rabbit antibody to 
hamster IgG (127-005-099; Jackson ImmunoResearch) in the presence of anti-cytokine 
antibodies from Bio X Cell (Cat #): anti-TGF-β (20 μg/ml, BE0057), anti-IFN-γ (5 μg/ml, 
BE0054) anti-IL-4 (5 μg/ml, BE0045), and anti-IL-12 (5 μg/ml, BE0052). One day after 
activation, cells were retrovirally transduced with individual TCRα chain of interest103. 2×105 
total cells (both transduced and non-transduced) were transferred into congenic CD45.1 
Foxp3IRES-GFP mice. 
The colon lamina propria and distal mesenteric lymph node (dMLN) were harvested at 
indicated times after transfer and analyzed by flow cytometry. Transferred TCR+ cells were 
identified as CD4+CD45.2+CD45.1–Vβ6+Vα2+ (CT2/CT6/CT9/T7-1).  
 
Antibiotic treatment  
Littermates were divided and treated at 3 weeks of age. Vancomycin (0.5 mg/ml), 
ampicillin (1 mg/ml), and neomycin (1 mg/ml) were administrated ad libitum via drinking water 
continuously for the time indicated. Metronidazole (1 mg/ml) was administrated by oral gavage 
every day for 1 week followed by gavage every other day104.  
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Bacterial culture and inoculation 
H. typhlonius (MIT 97-6810) and H. apodemus (MIT 03-7007) strains were cultured on 
Columbia agar (Oxoid) plate supplemented with 7% (v/v) defibrinated horse blood at 37°C under 
microaerobic conditions in a vented jar (Becton Dickinson) containing N2, H2 and CO2 (75:5:20) 
for 5 days; bacteria were collected into Brucella broth (BD Difco) and used for T-cell hybridoma 
assay or mice inoculation. For Helicobacter spp. inoculation studies, approximately 2×108 CFU 
bacteria were gavaged into indicated mice every other day for a total of 3 times. 
For culturing bacterial isolates used in Figure 2.3, strains 1B5PYG, 1E9PYG, 1B1MRS, 
1A6PYG, 1G6PYG, and 2F5PYG were grown in Peptone Yeast Glucose (PYG) medium 
(Anaerobe Systems) for 3 days at 37°C under anaerobic conditions in a Coy chamber. All other 
strains listed were cultured in Eggerth-Gagnon (EG) medium for 3 days at 37°C under anaerobic 
conditions in a Coy chamber as previously described30. Bacteria culture were collected and used 
for T-cell hybridoma assay. 
 
16S rRNA gene sequencing  
Colonic lumen contents or MA preparations were processed for DNA isolation using the 
ISOLATE Fecal DNA kit (Bioline). The V4 region of 16S rRNA gene was PCR amplified using 
barcoded primer described previously105, and sequenced using the Illumina Miseq Platform 
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(2×250bp paired-end reads). OTU picking was performed using UPARSE (usearch v.8.0.162)106, 
and taxonomy assigned using the uclust method with the Greengenes 13.8 database (QIIME 
v1.9107).  
 
PCR detection of Helicobacter spp. DNA  
Colonic lumen contents were processed for DNA isolation using the ISOLATE Fecal 
DNA kit. DNA samples (5 ng per sample in 20 μL reaction) were amplified using Helicobacter 
genus-specific primers C97 and C98108 generating a ~400bp product. PCR conditions: initial 
denaturation at 94°C for 2 min; followed by 32 cycles of: denaturation at 94°C for 30 sec, 
annealing at 55°C for 30 sec, and extension at 72°C for 30 sec; and a final extension at 72°C for 
7 min.  
 
Statistical analysis  
GraphPad Prism v7, R v3.3.0, and Qiime v1.9 were used for statistical and graphical 
analysis. Student’s t test, Mann-Whitney U test, one-way ANOVA, and two-way 
repeated-measures ANOVA were used for between-subjects analyses. Benjamini-Hochberg false 
discovery rate correction was used on Mann-Whitney U calculations for OTU comparisons.  
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2.4 Results 
Colonic Treg TCRs react to mucosal-associated bacterial antigens in vitro 
Our previous analysis of colonic Treg TCRs revealed direct recognition of antigens 
present in colonic contents103. Studies using two TCR Tg lines that express naturally occurring 
Treg TCRs (CT2 and CT6) suggested that these bacterial antigens are continually presented to 
the adaptive immune system, as we saw continuous pTreg induction from Tg cells101. However, 
specific bacterial species that elicit these T cell activations remain unknow. To address this, we 
assessed the in vitro reactivity of these TCRs to fecal antigen preparations presented on CD11c+ 
dendritic cells (DCs). Consistent with previous work, we saw limited but detectable activation by 
fecal antigen prepared from luminal content (Figure 2.1A). We therefore asked whether these 
TCRs show more reactivity to MA antigens, which might be predicted to have greater access to 
the immune system via DC uptake109, goblet associated passages110, or outer membrane 
vesicles111. Both CT2 and CT6 showed marked enhancement of TCR stimulation with MA 
compared with luminal antigen (Figure 2.1A). We then tested additional Treg TCRs, CT1, CT7, 
CT9 and T7-1, which we previously found to react to fecal antigens or commensal isolates in 
vitro103. Amongst these 6 colonic Treg TCRs, 4 showed high level reactivity in vitro to MA 
compared with luminal antigen.   
 
Colonic Treg TCRs react to Helicobacter spp. in vitro 
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To confirm that the reactivity in the MA antigen preparation was dependent on the 
microbiota, we treated SPF mice with a broad spectrum antibiotic combination of vancomycin, 
ampicillin, metronidazole, and neomycin (VAMN), and found that MA antigen no longer 
stimulated our 4 MA antigen reactive-Treg TCR panel (CT2, CT6, CT9, T7-1; Figure2.2A). This 
antibiotic cocktail includes vancomycin, which has been reported to decrease Treg cell numbers 
and Clostridium spp.31. We then tested the individual antibiotics to attempt to identify the 
bacterial spp. recognized by these TCRs by correlating in vitro TCR reactivity to MA antigen 
with changes in the bacteria composition. 
Unexpectedly, these data suggested that Helicobacter spp., and not the predicted 
Clostridium spp., were being recognized by the TCR panel. First, of the individual antibiotics, 
ampicillin and neomycin, but not vancomycin or metronidazole, markedly decreased the ability 
of MA antigen to stimulate the TCR panel compared with untreated controls (Figure 2.1B). 
Second, 16S ribosomal RNA (rRNA) gene sequences from the MA antigen preparations revealed 
that the two most frequent Operational Taxonomic Units (OTUs) lost with ampicillin or 
neomycin were Helicobacter typhlonius (H. typhlonius) and H. apodemus (Figure 2.1C, 2.2B).  
To determine if Helicobacter spp. were being directly recognized by these TCRs, we 
tested cultured isolates that matched the 16S rRNA sequence (Figure 2.1D). Notably, there were 
specific patterns of TCR reactivity, with CT9 and T7-1 recognizing both spp., whereas CT2 
reacted only to H. typhlonius, and CT6 to H. apodemus. Recognition of Helicobacter spp. in 
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vitro appeared to be TCR specific and not via a superantigen or other antigen-independent 
mechanism. First, each Helicobacter isolate stimulated only some, but not all, TCRs. Second, 
addition of anti-MHC II blocked TCR activation (Figure 2.2C). Third, testing of these TCRs 
against multiple bacterial isolates in vitro from different genera including Clostridium, 
Bifidobacterium, and Lactobacillus failed to activate our TCR panel to the same degree as 
Helicobacter (Figure 2.3). However, these TCRs could still show cross-reactivity to different 
bacterial species due to shared epitopes. CT6 may recognize other bacterial species as 
vancomycin reduced CT6 response to MA antigen without a corresponding decrease in H. 
apodemus frequency by 16S (Figure 2.1B and C). We have also shown previously that CT6 
reacted to an uncharacterized Clostridium spp.103. While the extent of bacterial cross-reactivity 
remains to be defined, these data clearly demonstrate that 4 of our 6 colonic Treg TCRs 
recognize Helicobacter spp. in vitro.  
 
Helicobacter spp. drives peripheral Treg cell development during homeostasis 
We then asked whether these Helicobacter spp. could induce TCR-specific Treg cell 
responses in vivo. As expected, transfer of CT2/CT6/CT9/T7-1 TCR+ cells into ampicillin-treated 
mice to eliminate pre-existing Helicobacter spp. (Figure 2.1C) resulted in little proliferation or 
differentiation (Figure 2.4A). However, inoculation of ampicillin-treated mice with a single 
Helicobacter spp. elicited robust expansion and Foxp3 upregulation in appropriate TCR+ Tg cells 
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(Figure 2.4A). Similarly, Helicobacter-free mice obtained from Charles River Laboratories 
showed little ability to induce TCR-dependent proliferation or Treg cell generation, unless the 
appropriate Helicobacter spp. identified in vitro (Figure 2.1D) was subsequently inoculated in 
vivo (Figure 2.4B and 2.5). Notably, as CT2 and CT6 Tg cells were co-transferred into the same 
host, it appears that these TCR clones show a high degree of specificity for individual 
Helicobacter strains (Figure 2.1D). To confirm that Treg induction occurs at polyclonal level, we 
analyzed the polyclonal CD4 T cells and observed a significant increase in Tregs in the cLP, 
specifically the Helioslo and Neuropilin-1 (Nrp1)lo Tregs which indicate pTreg cells112–114, as well 
as RORγT+ Tregs which represent bacterial-induced Treg cells115,116(Figure 2.6). Thus, these data 
demonstrate that Helicobacter spp. are a major driver of bacterial-specific Treg cell responses 
during homeostasis.    
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2.5 Discussion 
Our previous analysis of colonic Treg TCRs revealed direct recognition of antigens 
present in colonic contents103. Studies using two TCR Tg lines that express naturally occurring 
Treg TCRs (CT2 and CT6) suggested that these bacterial antigens are continually presented to 
the adaptive immune system, as we saw continuous pTreg induction from Tg cells101. However, 
specific bacterial species that elicit these T cell activations remain unknow. Here, we present data 
which shows that majority of the colonic Treg TCRs we identified are reactive against 
Helicobacter spp. residing in the mucosa. Additionally, colonization of SPF mice with these 
Helicobacter spp. induced efficient pTreg differentiation under homeostasis.  
The recognition that Helicobacter spp. are important inducers of antigen-specific Treg 
cells during homeostasis is consistent with a previous study117. Using a T cell transfer model of 
colitis, this study showed that CD45RBlow CD4+ cells from Helicobacter hepaticus-infected but 
not uninfected mice prevented colitis in Rag-/- hosts, suggesting that H. hepaticus infection 
resulted in the induction of Treg cells that prevented bacteria-induced colitis.  
A more recent study also showed that H. hepaticus selectively induces antigen-specific 
RORγt+Foxp3+ pTreg cells in the colon during homeostasis through c-Maf-dependent 
mechanism118.  
Helicobacter spp. are widely prevalent in mice colonies around the world119, and have 
often been thought of as pathobionts based on their ability to induce or enhance colitis in 
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lymphopenic mice120–122 or mice deficient in critical immuno-regulators such as IL-10123–125. The 
notion that Helicobacer spp. induce tolerogenic cells under steady state suggests that Treg cells 
play important roles in tolerance against gut pathobionts. Disruption of pTreg response by 
c-MAF deletion leads to accumulation of Th17 cells that potentiate colonic inflammation126.  
Clostridium clusters XIVa and IV are well known for increasing the frequency of Treg 
cell in the gut after introducing into GF mice. One potential mechanism for Clostridium-induced 
Treg selection may be mediated through the production of SCFAs. Clostridium spp. ferment 
dietary fiber to generate SCFAs which can act on DCs to promote tolerance127–129. Additionally, 
SCFAs can act directly on T cells themselves to promote colonic Treg cell expansion130. 
Hundreds of gut bacterial species form a complex ecosystem, it is reasonable to hypothesize that 
the effect of Helicobacter spp. on T cells could be affected by Clostridium or other microbial 
species. Therefore, future studies are needed to investigate whether the presence of other 
microbes could modulate Helicobacter-induced Treg response.  
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2.6 Figures 
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Figure 2.1 Colonic Treg TCRs react to mucosal-associated Helicobacter species.  
 (A) Treg TCRs preferentially react to mucosal-associated antigens (Ag). Hybridoma cells 
expressing different TCRs were cultured with CD11c+ dendritic cells and the indicated Ag. 
NFAT-GFP upregulation was assessed by flow cytometry 1.5 days later. (B) Selective 
elimination of MA Ag using individual antibiotics. TCRs from (A) that react to MA Ag were 
stimulated with colonic MA Ags isolated from antibiotic-treated or untreated mice as per (A). (C) 
Changes in H. typhlonius and H. apodemus OTUs correlate with in vitro reactivity to MA Ag in 
(B). Data shown are the percentage of 16S OTUs from the MA preparations of individual 
antibiotic-treated or untreated mice. (D) In vitro recognition of H. typhlonius or apodemus. 
Cultured isolates were tested for TCR reactivity in vitro as per (A). 2-3 independent experiments. 
Bars indicate mean.  
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Figure 2.2 Reactivity of colonic Treg TCRs to mucosal-associated Helicobacter species is 
MHCII dependent.   
(A) Broad spectrum antibiotics in vivo abrogate in vitro stimulation of indicated TCRs by MA Ag. 
As per Figure 2.1A, NFAT-GFP induction in hybridoma cells was assessed by flow cytometry 
after stimulating with MA Ags isolated from VAMN-treated or untreated mice. (B) Use of 
individual antibiotics to narrow down the bacterial stimulators in MA Ag. Shown are the 
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percentages of the top 10 most frequent 16S rRNA OTUs in the MA preparations from untreated 
mice (left) and their relative abundance in the MA preparations from individual antibiotic-treated 
mice (right). n=6, 5, 5, 3, 4. Unc, unclassified below taxonomy level. (C) Reactivity of 
CT2/CT6/CT9/T7-1 TCRs to Helicobacter spp. are blocked by antibody to MHC II. As per 
Figure 2.1D, NFAT-GFP induction in hybridoma cells was assessed after stimulating with 
cultured isolates with or without αMHC II. 2 independent experiments. Bars indicate mean ± 
SEM. 
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Figure 2.3 CT2/CT6/CT9/T7-1 TCRs do not react to other bacterial isolates tested.  
(A) Identification ID and Genus of bacterial isolates. (B) Hybridoma cells were stimulated with 
bacterial isolates indicated in (A), and assessed for NFAT-GFP as per Figure 2.1A. 1-2 
independent experiments. Bars indicate mean. 
36 
 
 
B
Ampicillin
Amp+
H. apodemus
R
e
la
ti
ve
 C
o
u
n
t
Cell Trace Violet
Ampicillin
Amp+
H. typhlonius
CT2 CT6
0 .0 0
0 .0 5
0 .1 0
0 .1 5
0 .2 0
0 .2 5
C T 2
C T 6
TC
R
+
o
f 
C
D
4
+
ce
lls
 (
%
)
D
iv
id
e
d
 o
f 
TC
R
+
ce
lls
 (
%
)
N
o
n
e
H
. t
yp
h
.
H
. a
p
o
.
gavage
A
2d
Ampicillin
2wk
gavage some mice with H. spp.(qod)
T cells i.v.
3 wk old 
SPF
7d
D
iv
id
e
d
 o
f 
TC
R
+
ce
lls
 (
%
)
0
5 0
1 0 0
* * * *
CT6
TC
R
+
o
f 
C
D
4
+
ce
lls
 (
%
)
Ampicillin
Amp + H. typhlonius
Tr
e
g
o
f 
TC
R
+
ce
lls
 (
%
)
cLP
C
T
2
C
T
9
T
7
-
1
0 . 0
0 . 1
0 . 2
0 . 4
0 . 6
0 . 8
1 . 0
*
*
p = 0 . 1 2
CT6
C
T
2
C
T
9
T
7
-
1
0
2 0
4 0
6 0
8 0
1 0 0 * * * *
* *
* * *
0
2 0
4 0
6 0
8 0
1 0 0 * *
0 . 0
0 . 5
1 . 0
1 . 5
2 . 0
2 . 5
p = 0 . 0 7
CT2 CT9 T7-1
Ampicillin
Amp + H. apodemus
0
20
100
80
60
40
CT2
0
5 0
1 0 0
* * * *
0
50
100
0 .0 0
0 .0 5
0 .1 0
0 .1 5
0 .2 0
0 .2 5
0
5 0
1 0 0
0
2 0
4 0
6 0
Tr
e
g
o
f 
TC
R
+
ce
lls
 (
%
)
N
o
n
e
H
. t
yp
h
.
H
. a
p
o
.
gavage
N
o
n
e
H
. t
yp
h
.
H
. a
p
o
.
gavage
Charles River CD45.1 hosts (dMLN)
analysis
37 
 
Figure 2.4 Helicobacter species induce peripheral Treg cell differentiation during 
homeostasis. 
 (A) In vivo validation of TCR reactivity to Helicobacter species. 3 week old SPF mice were 
treated with ampicillin (amp) for 2 weeks via drinking water. Two days after the last treatment, H. 
typhlonius or H. apodemus were gavaged 3 times total every other day. With the last gavage, 
congenically marked naïve CT2/CT6 Tg cells or retrovirally expressed CT9/T7-1 cells were 
transferred. Seven days post transfer, cLP cells were analyzed by flow cytometry for (top) 
development of Treg (Foxp3+) cells  (p=0.000003; 0.001; 0.0002; 0.0046; n=4, 5 for CT2; n=6, 
7 for CT9; n=5 for T7-1; n=3, 5 for CT6; Student’s t-test); (middle) frequency of transferred 
TCR-expressing cells amongst the host CD4+ T cells (p=0.0442; 0.021; 0.0046;0.0705; n=4, 5 
for CT2; n=6, 7 for CT9; n=5 for T7-1; n=3, 5 for CT6; Student’s t-test); or (bottom) CTV 
dilution  (p=0.00000002; 0.0000007; n=4, 5 for CT2; n=3, 5 for CT6; Student’s t-test). (B) T 
cell response to Helicobacter in vivo is species-specific. Three week old SPF mice obtained from 
Charles River Laboratories were gavaged with H. typhlonius or H. apodemus (3 times total every 
other day). With the last gavage, congenically marked naïve CT2 and CT6 Tg cells (105 each) 
were co-transferred. One week post-transfer, cells from the dMLN were analyzed by flow 
cytometry for the frequency of transferred TCR-expressing cells amongst the host CD4+ T cells 
(left); CTV dilution (middle); or development of Treg (Foxp3+) cells (right) (n=4, 6, 6). Bars 
indicate mean ± SEM. *p < .05, **p < .01, ***p < .001, ****p < .0001.  
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 n=4, 5 for CT2; n=3, 5 for CT6; Student’s t-test). (B) T cell response to Helicobacter in vivo is 
species-specific. Three week old SPF mice obtained from Charles River Laboratories were 
gavaged with H. typhlonius or H. apodemus (3 times total every other day). With the last gavage, 
congenically marked naïve CT2 and CT6 Tg cells (105 each) were co-transferred. One week 
post-transfer, cells from the dMLN were analyzed by flow cytometry for the frequency of 
transferred TCR-expressing cells amongst the host CD4+ T cells (left); CTV dilution (middle); or 
development of Treg (Foxp3+) cells (right) (n=4, 6, 6). Bars indicate mean ± SEM. *p < .05, **p 
< .01, ***p < .001, ****p < .0001.  
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Figure 2.5 Gating strategy and confirmation of Helicobacter spp. inoculation in Figure 2.4B.   
(A) Gating strategy for Figure 2.4B. (B) Confirmation of Helicobacter spp. inoculation in Figure 
2.4B. Helicobacter genus-specific primers were used to PCR colonic lumen contents of Charles 
River host mice gavaged with: no bacteria (lanes 1-4), H. typhlonius (lanes 5-10), and H. 
apodemus (lanes 11-16).  
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Figure 2.6 Relative expansion of pTregs in Helicobacter-colonized mice. 
Three week old SPF mice obtained from Charles River Laboratories were gavaged with H. 
apodemus (3 times total every other day). Two weeks after the last gavage, cells from the cLP 
were analyzed by flow cytometry for the frequency of Foxp3+ Tregs amongst the host CD4+ T 
cells (A); Helioslo Foxp3+ cells (B); Nrp1lo Foxp3+ cells (C); or RORγT+ Foxp3+ cells (D) 
amongst total Treg cells (n=9 each). Bars indicate mean ± SEM. *p < .05, **p < .01, ***p < 
.001, ****p < .0001.   
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Chapter 3: Characterization of T cell 
response to gut microbes in inflammation 
3.1 Abstract 
Specific gut commensal bacteria improve host health by eliciting mutualistic Treg cells 
responses. However, the bacteria that induce Teff cells during inflammation are unclear. Here, we 
addressed this by analyzing bacterial-reactive TCR transgenic cells and TCR repertoires in a 
murine colitis model. Unexpectedly, we found that mucosal-associated Helicobacter species 
triggered both Treg responses during homeostasis and Teff responses during colitis, as suggested 
by an increased overlap between the Teff/Treg TCR repertoires with colitis. By contrast, the 
marked expansion of luminal Bacteroides species seen during colitis did not trigger a 
commensurate Teff response. Unlike other Treg cell-inducing bacteria, Helicobacter species are 
known pathobionts and cause disease in immunodeficient mice. Thus, our study suggests a 
model in which mucosal bacteria elicit context-dependent Treg or effector cell responses to 
facilitate intestinal tolerance or inflammation.  
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3.2 Introduction 
We cohabitate with trillions of bacteria that reside within our intestines and provide 
important beneficial metabolic and immunologic functions131. However, inappropriate immune 
responses against these bacteria have been implicated in the pathogenesis of IBD132–134, as GF  
mice are highly resistant to many murine colitis models. Moreover, monocolonization studies of 
germ-free animals revealed that IBD development may be driven by specific commensal 
bacterial species135.  
Tolerance to commensal bacteria is thought to depend on Treg cells31,103,136, which we 
have recently shown can arise via pTreg cell development from naïve T cells in response to 
commensal antigens during homeostasis101. However, intestinal inflammation can result in the 
exposure of new antigens to the immune system.  In murine models, Teff cell generation to a 
commensal bacterial antigen was seen during intestinal inflammation, but not homeostasis44.  
Thus, it remains unknown whether effector responses during intestinal inflammation are driven 
by newly exposed antigens versus the commensal antigens that normally drive Treg cell 
development during homeostasis.   
IBD is associated with marked changes in the gut microbiota, a.k.a. dysbiosis137. 
Dysbiosis has been hypothesized to contribute to disease pathogenesis, as it is well established 
that different commensal bacterial species have distinct effects on the intestinal T cell population. 
For example, SFB strongly induces Th17 cells in the small intestine138, which has now been 
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confirmed by TCR transgenic studies139. By contrast, introduction of Clostridium clusters XIVa 
and IV30,31 or ASF140 markedly increased the frequency of colonic Treg cells in germ-free mice. 
Thus, changes in the microbiome may also affect the intestinal effector vs regulatory T cell 
population. 
Here, we used TCR repertoire analysis coupled with in vivo studies of 
commensal-specific TCRs to address the influence of colitis-mediated dysbiosis on 
bacteria-specific Treg cell development. We also examined the interaction of T cells with luminal 
versus mucosal associated antigens during homeostasis and colonic inflammation. Finally, we 
assessed the impact of commensal-specific T cells during lymphopenic conditions. In summary, 
our data suggest that the mucosal-associated pathobionts, Helicobacter spp., elicit 
context-dependent T cell responses during homeostasis and colitis.  
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3.3 Materials and Methods 
Study design 
Animal experiments were performed in a SPF facility in accordance with the guidelines 
of the Institutional Animal Care and Use Committee at Washington University. Host mice were 
housed together and interbred to maintain microbial integrity. Gender-matched littermate host 
mice were used for all comparisons. Cages were randomly assigned into different treatment 
groups. Both male and female mice were used. All in vivo and in vitro experiments were 
performed independently at least two times unless otherwise stated.  
 
Mice  
CT2, CT6 Tg mice22,101 were generated as described141 and bred to Rag1−/− [the Jackson 
Laboratory (JAX) #002216], Foxp3IRES-GFP (JAX #006772) or Foxp3IRES-Thy1.1 102, and/or 
IL-17AIRES-GFP (JAX #18472), and IFNγIRES-YFP(GREAT)142. TCli TCRβ Foxp3IRES-Thy1.1 TCRα+/– 
143 and TCli TCRβ144 Foxp3IRES-Thy1.1 Rag1–/– mice were previously described. IFNγIRES-YFP 
mice were a gift from Richard Locksley (UCSF); Foxp3IRES-Thy1.1 mice were a gift from 
Alexander Rudensky (MSKCC). Experiments in Figure 3.5 used Ly5.2 mice inbred in our 
colony as hosts; all other in vivo experiments used Foxp3IRES-GFP CD45.1 (JAX #006772) mice. 
All mice were on a C57BL/6 genetic background.  
 
Reagents, antibodies, and flow cytometry  
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Anti-IL-10R blocking antibody (BE0050) and isotype IgG1 (BE0088), anti-MHC II 
antibody (BE0108) were purchased from BioXCell. Fluorescently conjugated antibodies were 
purchased from Biolegend, eBioscience, and Becton Dickinson. Samples were analyzed using a 
FACSAria IIu (Becton Dickinson) and data were processed with FlowJo (Treestar).  
 
Cell isolation from the colonic lamina propria  
Cells were isolated as described101. Colonic segments were treated with RPMI medium 
containing 3% FBS and 20 mM HEPES (HyClone) with DTT (Sigma) and EDTA (Thermo 
Fisher) for 20 mins at 37°C with constant stirring. Tissue was further digested with 28.3 μg/ml 
liberase TL (Roche) and 200 μg/ml DNase I (Roche), with continuous stirring at 37°C for 30 
min. Digested tissue was forced through a Cellector tissue sieve (Bellco Glass) and passed 
through a 40 μm cell strainer.  
 
T-cell hybridoma stimulation assay 
T cell hybridoma cells expressing GFP under NFAT promoter102 were retrovirally 
transduced with TCRα chains of interest, as previously described103. Hybridoma cells (1.5 × 104) 
were cultured with flt3 ligand–elicited CD11c+ DCs (5 × 104) with and without the indicated 
antigen preparations (20 µg per well) in flat-bottomed 96-well plates. CD4+TCRα+ cells were 
analyzed for GFP expression after 1.5 days by flow cytometry. 
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Antigen preparations 
Total colonic lumen contents were collected from longitudinally opened colon and 
caecum, diluted with PBS (HyClone), vortexed, filtered through a 40 μm strainer, and 
autoclaved. For MA preparation, lumen contents were removed with forceps and the remaining 
tissue rinsed with PBS. Mucosal associated particles were released from colonic tissues using 
PBS with DTT (1 μM/ml) and EDTA (5 μM/ml) for 20 min at 37°C with constant stirring, 
followed by PBS with EDTA (2 μM/ml) for 3 times. From each of these steps, mucosal associate 
particles were filtered through a 40 μm strainer. Larger particles such as cells were removed by 
centrifugation at 1500 rpm for 10 min. The remaining particles in suspension were pelleted at 
2500 rpm for 15 min, resuspended in PBS, then autoclaved. For bacterial isolates, in vitro 
cultures were pelleted at 2500 rpm for 15min, washed twice with PBS, resuspended in PBS, and 
autoclaved for 45 min.   
 
Adoptive transfer experiments  
For experiments with CT2, CT6, or DP1 Tg cells, naïve T cells were FACS purified 
(CD4+ Foxp3− CD25− CD44lo CD62Lhi) from peripheral lymph nodes and spleen of CD45.2 
Foxp3IRES-GFP Rag1−/− or Foxp3IRES-Thy1.1 IL-17AIRES-GFP IFNγIRES-YFP Rag1−/− TCR Tg mice. 105 
naïve TCR Tg were injected retro-orbitally into congenic CD45.1 Foxp3IRES-GFP mice. In some 
experiments, cells were first labeled with CTV (Thermo Fisher) before injection.  
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For experiments using TCRs CT7, CT9, NT2, or T7-1, naïve T cells (CD4+ Foxp3− CD25− 
CD44lo CD62Lhi Vα2–) were FACS purified from CD45.2 Tcli TCRβ Foxp3IRES-Thy1.1 Tg mice 
(Rag1+/– or Rag1–/–), and activated in vitro with soluble anti-CD3 (0.1 μg/ml; 145-2C11; Bio X 
Cell) and anti-CD28 (1 μg/ml; 37.51; Bio X Cell) in tissue culture plates coated with rabbit 
antibody to hamster IgG (127-005-099; Jackson ImmunoResearch) in the presence of 
anti-cytokine antibodies from Bio X Cell (Cat #): anti-TGF-β (20 μg/ml, BE0057), anti-IFN-γ (5 
μg/ml, BE0054) anti-IL-4 (5 μg/ml, BE0045), and anti-IL-12 (5 μg/ml, BE0052). One day after 
activation, cells were retrovirally transduced with individual TCRα chain of interest (8). 2×105 
total cells (both transduced and non-transduced) were transferred into congenic CD45.1 
Foxp3IRES-GFP mice. 
The colon lamina propria and distal mesenteric lymph node were harvested at indicated 
times after transfer and analyzed by flow cytometry. Transferred TCR+ cells were identified as 
CD4+CD45.2+CD45.1–Vβ6+Vα2+ (CT2/CT6/CT7/ DP1/NT2) or CD4+CD45.2+CD45.1–
Vβ6+GFP+ (T7-1).  
 
Adoptive transfer of CBir1 Tg cells 
FACS purified (CD4+ CD25− CD44lo CD62Lhi) naïve T cells (2×105) from the spleens of 
CD45.1 CBir1 TCR Tg mice were injected retro-orbitally into congenic CD45.2 mice. Cells 
were first labeled with CTV before injection. The distal mesenteric lymph node was harvested 
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one week after transfer and analyzed by flow cytometry. Transferred TCR+ cells were identified 
as CD4+CD45.1+CD45.2–Vβ8.3+.  
 
Bacterial isolation, culture, and inoculation 
Colonic lumen contents from DSS+αIL10R treated mice were homogenized and serial 
dilutions were plated on brain-heart-infusion (BHI, BD Difco) agar supplemented with 10% 
(v/v) defibrinated horse blood (Colorado Serum Co.). Plates were grown for 3 days at 37°C 
under anaerobic conditions (5% H2, 20% CO2, and 75% N2) in a Coy chamber. 20 colonies 
were picked and 16S rRNA gene was sequenced. Colonies matched to B. vulgatus, B. 
acidifaciens, B. uniformis were cultured in BHI medium (EMD) supplemented with 5 g/L yeast 
extract, 0.5 g/L L-cysteine-HCl, 1 mg/L Vitamin K3, 1.2 mg/L Hematin (all Sigma), and used 
for T-cell hybridoma assay. H. typhlonius (MIT 97-6810) and H. apodemus (MIT 03-7007) 
strains were cultured on Columbia agar (Oxoid) plate supplemented with 7% (v/v) defibrinated 
horse blood at 37°C under microaerobic conditions in a vented jar (Becton Dickinson) containing 
N2, H2 and CO2 (75:5:20) for 5 days; bacteria were collected into Brucella broth (BD Difco) 
and used for T-cell hybridoma assay or mice inoculation.  
 
TCR sequencing 
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Tnaive (CD44lo CD62hi), Treg (Foxp3+), and Teff (CD44hi CD62Llo) CD4 T cells were 
sorted from TCli TCRβ Foxp3IRES-Thy1.1 TCRα+/- mice using BD FACSAria IIu. TCRα cDNA 
synthesis from purified cells was performed as described145. A two-step PCR was used to 
amplify multiple TRAV genes146 (multiplex PCR, table 3.1). Amplicons were purified after each 
PCR reaction using the Agencourt AMPure XP magnetic purification system. The ~200-600 bp 
amplicons were quantified using Qubit dsDNA BR assay kit (Invitrogen) and pooled in 
equimolar ratios for 250 bp paired end sequencing using Illumina MiSeq at the Washington 
University Genome Sequencing Center. Sequences were demultiplexed and analyzed using 
blastn to identify the TCR alpha variable (TRAV) and TCR alpha joining (TRAJ) gene segments 
using the IMGT database147. This information was then used to determine the CDR3 sequence. A 
unique TCR is identified by its TRAV and CDR3 amino acid sequence. Frequency filtering was 
applied to keep TCRs >0.1% of raw data in at least one sample. TRAVs with a frequency below 
1% of the total population in multiplex PCR were excluded to limit variability from low read 
numbers due to low primer efficiency. The filtered TRAVs accounted for more than 
76.2%±8.8% of the total TRAV repertoire. TRAV_CDR3 species frequencies were then 
multiplied by a correction factor determined by the ratio of TRAV sequences obtained using 
multiplex versus template switch PCR (Figure 3.3B)148.  
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16S rRNA gene sequencing  
Colonic lumen contents or MA preparations were processed for DNA isolation using the 
ISOLATE Fecal DNA kit (Bioline). For Figure 3.2E, terminal pellets were homogenized with 
PBS and prepared for Bacteria FACS sorting and 16S rRNA sequencing as in104. The V4 region 
of 16S rRNA gene was PCR amplified using barcoded primer described previously149, and 
sequenced using the Illumina Miseq Platform (2×250bp paired-end reads). OTU picking was 
performed using UPARSE (usearch v.8.0.162)150, and taxonomy assigned using the uclust 
method with the Greengenes 13.8 database (QIIME v1.9151).  
 
Colon histology 
Mouse colons were collected, luminal contents removed, cut open longitudinally, and 
pinned and fixed with 10% (vol/vol) formalin. Fixed samples were paraffin-embedded, cut into 
5μm sections, and stained with Hematoxylin and Eosin (H&E) by standard procedures. Crypt 
height was measured from digital photographs of H&E stained colon sections taken with a Nikon 
ECLIPSE 50i microscope.  
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Bacteria quantification by qRT-PCR 
Colonic lumen contents or MA preparations were processed for DNA isolation using the 
ISOLATE Fecal DNA kit. DNA samples (10 ng per sample in 10 μL reaction) were amplified 
using 16S universal primers 63F and 355R152 to yield a ~290bp product. PCR conditions: initial 
denaturation at 95°C for 10 min; followed by 40 cycles of: denaturation at 95°C for 15 sec, 
annealing at 55°C for 30 sec, and extension at 72°C for 30 sec; and a final extension at 72°C for 
7 min. qRT-PCR was done using DyNAmo ColorFlash SYBR green qPCR mix (Thermofisher) 
and Light Cycler 480 (Roche). Relative gene expression between groups were calculated using 
the ΔCt method.  
 
Human sample collection and preparation 
The human study protocol was approved by the Washington University Institutional 
Review Board. The healthy controls, Crohn’s disease (CD) or ulcerative colitis (UC) patients 
were recruited through participant registries and physician's clinics. Fresh fecal samples were 
collected at home, stored at −20°C in an insulated shipper, mailed to or brought in person to 
Washington University in St. Louis either the same day or overnight and then stored at −80°C 
until further analysis. Colonoscopy samples were collected by aspirating mucosal fluid during 
the colonoscopy from the specified intestinal locations. A short questionnaire was administrated 
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to collect participants’ health information. Informed consent was obtained from all subjects. 
Fecal samples or colonoscopy samples were homogenized with PBS and prepared for Bacteria 
FACS sorting and 16S rRNA sequencing as in153.  
 
Statistical analysis  
GraphPad Prism v7, R v3.3.0, and Qiime v1.9 were used for statistical and graphical 
analysis. Student’s t test, Mann-Whitney U test, one-way ANOVA, and two-way 
repeated-measures ANOVA were used for between-subjects analyses. Benjamini-Hochberg false 
discovery rate correction was used on Mann-Whitney U calculations for OTU comparisons. 
Morisita-Horn statistical test was used for TCR repertoire comparison. TCR Renyi diversity 
profiles were generated as previously indicated154, using Renyi entropy values with α/order 
values ranging from 0 (natural logarithm of species richness) through 2 (natural logarithm of the 
inverse Simpson index). This includes α= 1, which represents the commonly used Shannon 
entropy.   
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3.4 Results 
Overlap of effector and Treg TCR antigen-specificity during colitis.  
To address the effect of colitis on T cell responses to commensal bacteria, we examined 
induced models as we wanted to compare mice that started with the same microbiota. We settled 
on a murine model of inflammatory colitis (Figure 3.1A)155 that incorporates 1% DSS induced 
mucosal injury along with anti-IL-10R antibody (αIL10R)80,156, which blocks an important 
immune regulatory pathway implicated in human IBD in genome-wide association studies157. 
DSS+IL10R treatment induced colitis as evidenced by weight loss, increased colon 
weight/length ratio, and a marked enhancement of Teff (CD44hiCD62Llo) and Treg cells (Figure 
3.2). As the combination showed a greater effect on the microbiota than DSS or αIL10R alone 
(Figure 3.2E), we used DSS+aIL10R for subsequent experiments. 
Consistent with previous reports, naïve T cells from CT2 and CT6 TCR Tg lines, which 
express TCRs isolated from colonic Treg cells and recognize commensal antigens103, showed 
substantial induction of Foxp3, the canonical Treg cell transcription factor, by 1 week after 
transfer into control IgG treated mice (Figure 3.1A and B)98. However, in mice undergoing 
DSS+IL-10R mediated colitis, they skewed towards Teff cell generation (Figure 3.1B). Teff 
cell differentiation was primarily to the Th17 phenotype based on IL-17AGFP and IFNYFP 
reporters (Figure 3.1C), consistent with observations in human Crohn’s disease158. In addition, 
CT2 and CT6 cells underwent extensive proliferation as assessed by CTV dilution and expanded 
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as a fraction of total CD4+ cells (Figure 3.1D and E). Thus, the normal tolerogenic Treg cell 
developmental response to commensal bacterial antigens can be re-directed to a Th17 effector 
response during experimental colitis.   
 
Shared TCR usage between Treg and Teff during colitis 
To assess whether the responses of CT2 and CT6 TCR Tg cells were representative of the 
T cell population, we analyzed the effect of colitis on the TCR repertoire (Figure 3.3A and B, 
table 3.1). Because the great diversity in polyclonal T cells precludes experimental analysis at the 
individual TCR level, we utilized mice in which TCR diversity is limited by a transgenic fixed 
TCRβ chain158. Although TCR diversity is diminished, this approach allows high-throughput 
analysis of the TCR repertoire at the individual TCR level via sequencing of the variable TCRα 
chains. With colitis, both Treg and Teff repertoires showed increased clonal expansion compared 
to controls (Figure 3.3C), consistent with a T cell response. Notably, we saw a marked increase 
in similarity between the Treg and Teff TCR repertoires within the cLP of individual mice 
during colitis compared with controls (Figure 3.3D and 3.4A). Examination of the top 25 Teff 
TCRs per mouse showed that many of these TCRs are also found in the Treg cell subset during 
colitis (Figure 3.4B), consistent with our TCR transgenic studies (Figure 3.1). In control mice, 
the relatively low degree of overlap between the Teff and Treg cell subset within individual mice 
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(Figure 3.4A and B, 3.3D) is consistent with our previous studies103,159. As before, we also 
observed mouse-to-mouse variability of Teff and Treg TCR repertoires between mice (Figure 
3.4A, 3.3D and E). To confirm the TCR repertoire analysis, we cloned T7-1 (Figure 3.4C), the 
most abundant TCR found in the Teff subset of colitic mice by mean percentage (Figure 3.3E). 
As predicted by the TCR repertoire study, analysis of adoptively transferred peripheral TCli- 
TCR Tg cells expressing T7-1 showed that this TCR facilitated Foxp3 induction during 
homeostasis, but skewed towards Teff cell generation with colitis (Figure 3.4D). Thus, these data 
demonstrate an increased overlap between the Teff and Treg TCRs repertoires during colitis that 
does not occur at homeostasis.  
Our TCR Tg data suggest that the overlap in Treg and Teff TCR usage during colitis is 
due to enhanced Teff generation by clones that might normally differentiate into Treg cells 
(Figure 3.1). Alternatively, the overlap may arise from increased Treg cell generation by Teff 
TCRs during colitis. However, transfer of CBir1 Tg cells158  into DSS+αIL10R hosts showed 
increased Teff but not Treg generation (Figure 3.5), consistent with a previous report in the DSS 
model44. Although it remains possible that the CBir1 result in the DSS+αIL10R model is not 
generalizable to other model systems, in conjunction with the TCR repertoire analysis, these 
TCR Tg studies suggest that colitis skews T cell development such that pro-inflammatory Teff 
cells often use the same TCRs as anti-inflammatory Treg cells.   
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Marked changes in bacterial composition with colitis 
The observation that colitis increased the proliferation of adoptively transferred CT2 and 
CT6 TCR Tg cells (Figure 3.1B) suggested that there might be alterations in the colonic 
microbiota. We therefore analyzed the changes in the MA and luminal 16S rRNA profile with 
colitis. Consistent with previous reports, the bacterial composition in the lumen versus mucosa is 
quite distinct (Figure 3.6A-C)160,161. In the MA preparation, we noted a high frequency of 
Helicobacter spp. in both control and colitic mice (Figure 3.6B), consistent with the activation 
and differentiation of CT2 and CT6 Tg cells in vivo under both conditions (Figure 3.1). The 
frequency of H. typhlonius was further increased in colitic mice (Figure 3.6D and E), which may 
suggest enhanced antigen stimulation for H. typhlonius-reactive TCRs. In the lumen, besides the 
increase in H. typhlonius (Figure 3.6D and E), we noted that colitis induced a marked expansion 
of Bacteroides (B.) spp., particularly B. vulgatus, which represented over 20% of 16S reads in 
some mice (Figure 3.6D and F). As there was no obvious decrease in bacterial density (Figure 
3.7), these data suggest that DSS+αIL10R colitis is associated with a major bloom of 
Bacteroides spp. in the lumen.  
 
Lack of T cell responses to the bloom of luminal Bacteroides species during colitis  
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As Bacteroides species have been suggested to be important triggers of intestinal 
inflammation in other murine models162,163, we asked whether the dramatic expansion of 
Bacteroides species in DSS+IL10R treated mice induced strong anti-microbial effector T cell 
responses. We assessed the in vivo responses of several TCRs that recognize Bacteroides strains 
isolated from DSS+IL10R mice in vitro, including the B. vulgatus-reactive TCR DP1 (Figure 
3.8A, table 3.2). These TCRs recognized Bacteroides strains through MHC II and did not 
respond in vitro to the Helicobacter strains tested (Figure 3.9A and B). To our surprise, 
adoptively transferred T cells expressing these Bacteroides-reactive TCRs did not show 
increased proliferation, expansion, or Teff cell development in DSS+IL10R treated mice 
compared with controls (Figure 3.8B and C). Consistent with the poor expansion, very few 
transferred cells were recovered from the colon. In fact, the percentage of the transferred 
TCR-expressing cells amongst total CD4+ T cells was reduced during DSS+IL10R colitis 
(Figure 3.8C), implying that these antigens are relatively less important during colitis despite 
their bloom in the lumen. We confirmed in vitro that the luminal antigens for DP1 and NT2 
increased with colitis (Figure 3.8D), as predicted based on 16S rRNA sequencing (Figure 3.6F). 
By contrast, MA antigen showed lower stimulatory ability than luminal antigen for DP1 and 
NT2 even during colitis (Figure 3.8D). We also checked that the Helicobacter spp.-reactive 
TCRs (Figure 2.1) did not respond to these Bacteroides strains (Figure 3.9B). Although it 
remains possible that these Bacteroides-reactive TCR clones do not compete well in the gut or 
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are not representative of polyclonal T cell responses to Bacteroides, these data suggest that the 
marked expansion of luminal Bacteroides spp. in this model of colitis does not elicit a 
corresponding increase in antigen-specific T cell responses.  
 
Pathogenic potential of Helicobacter-reactive TCRs 
The differentiation of colonic Treg TCRs into Teff cells during colitis (Figure 3.1) 
suggests that the altered T cell response to bacterial antigens may contribute to colonic 
inflammation. To test the pathogenic potential of these Helicobacter spp.-reactive TCRs, we 
adoptively transferred naïve CT6 Tg cells into Rag1–/–  hosts with or without H. apodemus 
inoculation. In contrast with wild-type hosts, H. apodemus drove antigen-specific Teff 
generation of CT6 Tg cells (Figure 3.10A) in Rag1–/– hosts likely due to expansion in a 
lymphopenic environment. In line with a Teff response, we observed colonic inflammation in 
CT6-transferred hosts only in the presence of H. apodemus as evidenced by increased colon 
weight/length ratio and crypt dropout in histology (Figure 3.10B and C). Similarly, Teff response 
of CT2 Tg cells to H. typhlonius lead to colonic inflammation in Rag1–/– hosts (Figure 3.11). We 
did not note major weight loss induced by these TCR Tg cells and/or Helicobacter spp. during 
the time frame of this experiment (Figure 3.11Dand E), in contrast with polyclonal T cell transfer 
models164. This could be due to limited systemic effects from a single TCR clone or differences 
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in gut microbiota composition. Although Helicobacter spp. without T cell transfers have been 
reported to induce colitis in Rag-deficient mice165–168, we did not observe inflammation caused 
by these two strains during the period of the experiment (Figure 3.10 and 3.11). Thus, these data 
demonstrate the potential pathological consequences of antigen-specific Teff expansion against 
gut bacteria.   
Finally, mucosal associated enterohepatic Helicobacter spp. in humans have been 
suggested to be associated with IBD169. We have also detected the presence of Helicobacter spp. 
in patients with CD or UC by 16S rRNA sequencing of fecal or colonoscopy samples (Figure 
3.12). However, it remains to be established whether these Helicobacter spp. play a similar 
immunomodulatory role in humans as seen in our mouse studies.   
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3.5 Discussion 
Based on this study of T cell responses to commensal antigens during experimental 
colitis, we make the following observations: First, effector T cell responses during colitis are 
often to commensal antigens normally presented to the immune system during homeostasis, and 
not to antigens normally excluded by the mucosal barrier. Second, commensal bacterial species 
vary widely in their ability to induce T cell responses due in part to their anatomic location 
relative to the mucosal surfaces. Third, constitutively presented antigens appear to primarily 
elicit Treg cell responses during homeostasis, implying that tolerance to these antigens is 
important to preventing colitis. Finally, Helicobacter spp. are important inducers of T cell 
responses during homeostasis and colitis. Thus, these data suggest a model whereby Treg 
cell-mediated tolerance, and not effector cell mediated immunity, is required against commensal 
bacteria such as Helicobacter spp. that routinely interact with the host immune system.  
Our initial goal was to study the T cell response to alterations in gut microbiota structure, 
a.k.a dysbiosis, that occurs with colitis and IBD and has been proposed to be involved in disease 
pathogenesis133,135,136. However, rather than observing a dominant effector T cell response to 
Bacteroides spp. that bloom during colitis, the major stimulators were Helicobacter spp. that 
routinely interact with T cells during homeostasis. These data do not exclude the possibility that 
dysbiosis of Bacteroides spp. may exert non-antigen dependent effects on T cell immunity 
through changes in short chain fatty acids170–172, polysaccharides173, and aryl hydrocarbon 
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receptor ligands173. Furthermore, as our studies were done in specific-pathogen-free mice, 
variability in gut flora composition as well as strain-level differences could affect the functional 
outcome of specific bacteria. Nonetheless, these data suggest that dysbiosis during intestinal 
inflammation may not provide an important antigen-specific trigger of effector responses that 
contribute to colitis. 
The relative inefficiency of Bacteroides spp. to induce T cell activation is correlated with 
their bacterial distribution, as they are preferentially found in the lumen. By contrast, mucosal 
associated Helicobacter spp. were potent stimulators of T cell response. This is consistent with a 
recent study of SFB showing that tight attachment to the intestinal epithelium plays an important 
role in eliciting Th17 cells173. Thus, understanding the adaptive immune response to commensal 
bacteria may be facilitated by analysis of mucosal- or epithelial-associated, and not luminal, 
bacteria. 
Our observation that the normal pTreg development to Helicobacter spp. is skewed 
towards Th17 effector response during colitis is also consistent with a recent paper studying T 
cell response to H. hepaticus126. Considering that Helicobacter spp. are pathobionts that can 
induce or enhance colitis in several mice models, these data therefore argue that our current 
notion of Treg inducing bacteria as being “good bacteria” that are protective against colitis may 
be incomplete21,174. In fact, T cell development to gut bacteria may be context-dependent, being 
tolerogenic during homeostasis, and inflammatory during lymphopenia or experimental colitis.  
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A final implication of this study is that T cell-mediated intestinal inflammation may be 
driven by bacteria that are always in contact with the adaptive immune system, rather than 
species that are mostly excluded from being presented to T cells during homeostasis. This 
contrasts with a previous study of CBir1 TCR Tg cells, which recognize a commensal 
bacteria-expressed flagellin173 that is presented to the immune system primarily during 
inflammation175. In this case, the CBir1 antigen is normally not seen by the immune system and 
might be considered a pathogen when seen in the context of inflammation. However, in the 
DSS+IL10R model of colitis, this type of immune response to commensal antigens appears to 
be less relevant.  Thus, our studies bring up an interesting question, that is, to what extent is the 
human intestinal inflammatory T cell response directed towards commensal antigens that the 
host is commonly in contact with, i.e. akin to “self” antigens, or commensal antigens that are 
only presented during injury, i.e. “foreign” antigens.  
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3.6 Figures 
 
 
Figure 3.1 Colonic Treg TCRs (CT2 and CT6) drive effector T cell development in 
inflammation. 
 (A) Experimental model. CD45.1 4-5 week old SPF mice were administered αIL10R (1 
mg/mouse) on day 0 and kept on 1% DSS water for 7 days to initiate colitis. Control mice were 
given isotype IgG (1 mg/mouse) on day 0. Four days after initiation of colitis, congenically 
marked naïve CT2/CT6 Tg cells (105) were intravenously transferred and analyzed 7 days later. 
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(B to D) Effector cell induction and expansion with colitis. Transferred TCR Tg cells from the 
colon lamina propria (cLP) were analyzed by flow cytometry for (B) development of Teff 
(CD44hi CD62Llo Foxp3–) and Treg (Foxp3+) makers (p=0.000003; 0.0007; 0.0024; 0.0157; 
n=10; Student’s t-test); (C) upregulation of cytokines using IL-17AGFP and IFNγYFP 
(p=0.000001; 0.0007; 0.0029; n=10 for CT2; n=7 for CT6; Student’s t-test); (D) proliferation 
indicated by Cell Trace Violet (CTV) dilution (p=0.000002; 0.00002; n=10 for CT2; n=7, 8 for 
CT6; Student’s t-test); and (E) expansion indicated by the in vivo frequency amongst the host 
CD4+ T cells (p=0.00005; 0.0275; n=10 for CT2; n=10, 11 for CT6; Student’s t-test). Bars 
indicate mean ± SEM. *p < .05, **p < .01, ***p < .001, ****p < .0001.  
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Figure 3.2 DSS+IL10R treatment induces colitis and effector T cell responses. 
DSS or DSS+IL10R mediated colitis was induced per Figure 3.1A, and assessed for: (A) Body 
weight change (two-way repeated measures ANOVA with Tukey’s post-hoc test: p=0.0163;  
n=13, 14, 14). (B) Colon weight/length ratio at 2 weeks (one-way ANOVA with Tukey’s 
post-hoc test: p=0.0015 IgG vs DSS+αIL10R; 0.0082 DSS+IgG vs DSS+αIL10R; n=6). (C) 
Percentage and number of Teff (CD44hi CD62Llo) or Treg (Foxp3+) cells by flow cytometry from 
cLP of IgG, DSS+IgG, or DSS+αIL10R-treated mice at 2 weeks (one-way ANOVA with 
Tukey’s post-hoc test: Treg%: p=0.0000005 IgG vs DSS+αIL10R; 0.00002 DSS+IgG vs 
DSS+αIL10R; Teff number: 0.0002 IgG vs DSS+αIL10R; 0.0002 DSS+IgG vs DSS+αIL10R; 
Treg number: 0.00003 IgG vs DSS+αIL10R; 0.00005 DSS+IgG vs DSS+αIL10R; n=8). (D) 
Gating strategy for (C). (E) Bacterial composition changes with colitis. Mean relative bacterial 
frequencies at the phyla level by 16S rRNA sequencing of terminal fecal samples at 2 weeks are 
shown (n=8, 8, 4, 8). Bars indicate mean ± SEM. *p < .05, **p < .01, ***p < .001, ****p < 
.0001.   
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Figure 3.3 Effects of DSS+IL10R-mediated colitis on the TCR repertoire. 
Colitis was induced in TCR Tg mice as per Figure 3.1A. (A) Summary of cell number, 
sequencing reads, and unique TCRαs (TRAV_CDR3) for each of the sorted T cell populations in 
the cLP or dMLN used for the TCR repertoire analysis with multiplex PCR. (B) Correction 
factor for individual TRAVs. Two biologic, each with 2 technical, replicates were sequenced 
using multiplex or template switch PCR. The mean TRAV percentages are shown. Correction 
factor = TRAV percentage in template switch divided by percentage in multiplex sequences. (C) 
Increased colonic Treg and Teff clonality with inflammation. Shown are the mean Renyi entropy 
(y-axis), a measure of diversity in the TCR repertoires, versus order (x-axis), i.e. the weight of 
high-frequency clones in the analysis. A more rapid drop in entropy with increasing order 
indicates greater dominance by higher frequency clones. (D) Morisita-Horn similarity 
comparison of TCRα sequences from the dMLN between two different T cell subsets within 
each mouse (left) or between mice comparison of each T cell subset (right). Bars indicate mean ± 
SEM. Student’s t-test. (E) Heatmap showing the percentage of top 25 Teff TCRs by mean 
frequency (right to left) from DSS+αIL10R mice, and their corresponding percentages in 
IgG-treated control mice.   
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Figure 3.4 Treg and Teff subsets show increased TCR overlap during colitis. 
 (A to C) Analysis of TCRα repertoires from Tnaive (CD44lo CD62hi), Treg (Foxp3+), and Teff 
(CD44hi CD62Llo) cells in the cLP of TCli TCRβ Foxp3IRES-Thy1.1 Tcra+/− mice 2 weeks after 
initiation of IgG or DSS+αIL10R. n=5, 6. (A) Morisita–Horn similarity comparison between two 
different T cell subsets within each mouse (left) or between different mice within each T cell 
subset (right). An index value of 1 indicates that the two samples are completely similar and an 
index value of 0 means they are completely dissimilar (left: p=0.009; n=5,6; right: p=0.033; 
0.014; n=10,15; Student’s t-test). (B) Heatmap showing the top 25 Teff TCRs in one mouse per 
row and their corresponding percentage in the Treg subset. Note that each column does not 
represent one TCR across all mice. (C) Percentage of T7-1 TCR in repertoire of Tnaive, Treg, 
and Teff subsets. Each dot represents data from an individual mouse. (D) In vivo analysis of T7-1 
TCR. T7-1 was retrovirally transduced into in vitro activated naïve TCliβ Rag1–/– Tg cells and 
2x105 cells were transferred into IgG or DSS+αIL10R hosts as indicated in Fig. 1A. Seven days 
post-transfer, cells from the cLP were analyzed by flow cytometry for Teff and Treg cells, and 
the in vivo frequency amongst the host CD4+ T cells (p=0.029; n=4; Student’s t-test). Bars 
indicate mean ± SEM. *p < .05, **p < .01, ***p < .001, ****p < .0001. 
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Figure 3.5 CBir1 TCR Tg cells become Teff, and not Treg, cells during DSS+IL10R colitis. 
Congenically marked naïve CBir1 Tg cells (2х105) were intravenously transferred into IgG or 
DSS+αIL10R mice and analyzed 7 days later as indicated in Figure 3.1A. (A) Transferred CBir1 
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Tg cells from dMLN were analyzed by flow cytometry for expansion based on the frequency of 
CBir1 cells amongst the host CD4+ T cells; proliferation reported by CTV dilution; and the 
development of Teff (CD44hi CD62Llo Foxp3–) and Treg (CD25+) markers (p=0.0353; n=5; 
Student’s t-test). Bars indicate mean ± SEM. *p < .05, **p < .01, ***p < .001, ****p < .0001. 
(B) Gating strategy for (A). 
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Figure 3.6 DSS+αIL10R colitis is associated with differential changes of bacterial 
composition in the lumen and mucosa. 
 (A to D)16S rRNA sequencing of colonic lumen contents or MA preparations 2 weeks after 
initiation of IgG or DSS+αIL10R. n=8. Data shown are mean bacterial changes at the phyla (A) 
or family (B) level, and principal coordinates analysis on unweighted UniFrac distances (C). (D) 
Bacteria enriched during colitis. Shown are OTUs enriched in DSS+αIL10R mice with average 
percentage >1% and Benjamini-Hochberg adjusted p value <0.05 (Mann-Whitney U) from 
lumen contents or MA preparations. (E) Increase of H. typhlonius in the mucosa with colitis. 
Percentages of H. typhlonius and H. apodemus OTUs are shown (Benjamini-Hochberg adjusted p 
value: p=0.0009; 0.0023; 0.0277; n=8; Mann-Whitney U test). (F) Marked expansion of 
Bacteroides species in the lumen with colitis. Percentages of B. vulgatus, B. acidifaciens, and B. 
uniformis OTUs are shown (Benjamini-Hochberg p=0.0009; 0.0086; 0.0009; 0.0086; 0.0266; n=8; 
Mann-Whitney U test). Bars indicate mean ± SEM. *p < .05, **p < .01, ***p < .001, ****p < 
.0001.  
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Figure 3.7 Quantification of 16S rRNA gene abundance in the lumen or MA preparation.  
The relative amount of 16S rRNA is estimated based on 1/(2^Ct from real-time PCR) × DNA 
amount/mg of fecal or MA sample. Values are then normalized to the average in the IgG 
condition, and therefore indicate the relative 16S rRNA fold change compared to controls (IgG). 
n=6. Bars indicate mean ± SEM. Student’s t-test.   
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Figure 3.8 Expansion of Bacteroides species during colitis does not enhance TCR-specific T 
cell responses. 
(A) Antigenic reactivity of Bacterioides-reactive TCRs used. In vitro stimulation by the 
Bacteroides isolates are shown as per Figure 2.1A. 2-3 independent experiments. (B and C) In vivo 
expansion and effector cell development of Bacteroides-reactive T cells. Congenically marked 
naïve DP1 Tg cells (105) were transferred into CD45.1 hosts as indicated in Figure 3.1A, and 
analyzed 7 days post-transfer by flow cytometry for (B) CTV dilution in the dMLN (n=7), (C, left) 
frequency amongst the host CD4+ T cells (p=0.0005; 0.047; n=7 for DP1 and NT2; n=9 for CT7; 
Student’s t-test), and (C, right) development of Teff (CD44hi CD62Llo Foxp3–) (n=7 for DP1 and 
NT2; n=11 for CT7; Student’s t-test). NT2 and CT7 (C) were retrovirally transduced into in vitro 
activated naïve Vα2– TCliβ Tg cells from Rag1+/– (black) or Rag1–/– (blue) mice before transfer of 
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2x105 cells. (D) In vitro reactivity to in vivo Ag preparations is consistent with Bacteroides 
expansion by 16S rRNA analysis. Colonic lumen contents or MA preparations from IgG or 
DSS+αIL10R mice were tested as per Figure 2.1A. 2 independent experiments. Bars indicate mean 
± SEM. *p < .05, **p < .01, ***p < .001, ****p < .0001.   
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Figure 3.9 Specificity of DP1/NT2/CT7 TCRs for Bacteroides spp.   
(A) Reactivity of DP1/NT2/CT7 TCRs to Bacteroides spp. are blocked by antibody to MHC II as 
per Figure 2.2C. (B) DP1/NT2/CT7 TCRs do not react to Helicobacter spp. in vitro using the 
assay described in Figure 2.1A. (C) CT2/CT6/CT9/T7-1 TCRs do not react to Bacteroides spp. 
in vitro using the assay described in Figure 2.1A. 2-3 independent experiments. Bars indicate 
mean ± SEM. 
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Figure 3.10 Pathogenic potential of naive Helicobacter-reactive CT6 cells in lymphopenic 
mice. 
Six week old Rag1–/– mice were given H. apo. with or without naïve CT6 T cell transfer. H. apo. 
was gavaged 3 times total every other day. Naïve CT6 cells (105) was transferred at the time of last 
gavage. (A) Flow cytometry analysis for the frequency of Tg cells amongst the host CD45+ cells 
(one-way ANOVA, Turkey’s post-hoc test: p=0.0002 CT6 vs CT6+H. apo.; n=3, 5, 5, 5), and 
development of Treg (Foxp3+) and Teff (CD44hi CD62Llo Foxp3–) markers (n=5) in dMLN at 6 
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weeks. (B) Colon weight/length ratio at 6 weeks (one-way ANOVA with Turkey’s post-hoc test: 
p=0.0003 No treatment vs CT6+H. apo.; 0.00002 CT6 vs CT6+H. apo.; 0.0005 H. apo. vs 
CT6+H. apo.; n=3, 5, 5, 5). (C) Representative haematoxylin/eosin-stained section of the 
ascending colon at 6 weeks (original magnification ×10), and quantification of crypt number 
(one-way ANOVA with Tukey’s post-hoc test: p=0.00007 No treatment vs CT6+H. apo.; 
0.00005 CT6 vs CT6+H. apo.; 0.0003 H. apo. vs CT6+H. apo.; n=3).  The number of crypts 
observed per 100μm of ascending colon was averaged from five fields. Decreased crypt number 
reflect crypt dropout due to inflammation. Bars indicate mean ± SEM. *p < .05, **p < .01, ***p 
< .001, ****p < .0001. 
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Figure 3.11 Bacterial-specific induction of colitis by CT2 in lymphopenic mice. 
 (A to C) CT2 Tg cells induce colonic inflammation only in the presence of H. typhlonius. Six 
week old Rag1–/– mice were given H. typh. with or without naïve CT2 T cell transfer, similar to 
Figure 3.10 (A) Flow cytometry analysis for the frequency of Tg cells amongst the host CD45+ 
CT2 + H. typh.
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cells (left) (one-way ANOVA with Turkey’s post-hoc test: p=0.0235 CT2 vs CT2+H. typh.; n=4, 
5, 7), and development of Treg (Foxp3+) and Teff (CD44hi CD62Llo Foxp3–) markers (right) 
(n=7) in dMLN at 6 weeks. (B) Colon weight/length ratio at 6 weeks (one-way ANOVA with 
Tukey’s post-hoc test: p=0.00007 CT2 vs CT2+H. typh.; 0.00003 H. typh. vs CT2+H. typh.; n=4, 
5, 7). (C) Representative haematoxylin/eosin-stained section of the transverse colon at 6 weeks 
(original magnification ×10). (D) Body weight change of CT6 experiment shown in Figure 3.10 
(two-way repeated measures ANOVA with Tukey’s post-hoc test: p=0.0247 No treatment vs 
CT6+H. apo.; n=4, 5, 7). (E) Body weight change of CT2 experiment in (A to C) above. n=4, 5, 
7; two-way repeated-measures ANOVA. Bars indicate mean ± SEM. *p < .05, **p < .01, ***p 
< .001, ****p < .0001. 
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Figure 3.12 Helicobacter spp are detected in fecal and colonoscopy samples from IBD 
patients. 
 (A) Demographic information of subjects and Helicobacter OTUs identified by 16S rRNA 
sequencing. (B) Percentage of H. apodemus or H. mastomyrinus OTUs of all 16S rRNA 
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sequences in fecal samples from healthy controls, UC, or CD patients. (C) Percentage of H. 
apodemus, H. mastomyrinus, or H. typhlonius OTU of all 16S rRNA sequences in colonoscopy 
samples from healthy controls, UC, or CD patients. 
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3.7 Tables 
 
Series ID-TRAV ID Primer Sequence
Mi1mx-TRAV1 ACACGACGCTCTTCCGATCTGGTTATCCTGGTACCAGCA
Mi1mx-TRAV2 ACACGACGCTCTTCCGATCTCATCTACTGGTACCGACAGG
Mi1mx-TRAV3 ACACGACGCTCTTCCGATCTGGCGAGCAGGTGGAG
Mi1mx-TRAV4 ACACGACGCTCTTCCGATCTTCTGSTCTGAGATGCAATTTT
Mi1mx-TRAV5-1/4(D) ACACGACGCTCTTCCGATCTATYCGTTCAAATATGGAAAGAAA
Mi1mx-TRAV6-1/2 ACACGACGCTCTTCCGATCTCAGATGCAAGGTCAAGTGAC
Mi1mx-TRAV6-3/4(D) ACACGACGCTCTTCCGATCTAAGGTCCACAGCTCCTTC
Mi1mx-TRAV6-5/7(D) ACACGACGCTCTTCCGATCTGTTCTGGTATGTGCAGTATCC
Mi1mx-TRAV6-6 ACACGACGCTCTTCCGATCTAGATTCCGTGACTCAAACAG
Mi1mx-TRAV7 ACACGACGCTCTTCCGATCTCAKGRCYTCYYTCAACTGCAC
Mi1mx-TRAV8 ACACGACGCTCTTCCGATCTGAGCRTCCASGAGGGTG
Mi1mx-TRAV9 ACACGACGCTCTTCCGATCTCCAGTGGTTCAAGGAGTG
Mi1mx-TRAV10/(D) ACACGACGCTCTTCCGATCTAGAGAAGGTCGAGCAACAC
Mi1mx-TRAV11 ACACGACGCTCTTCCGATCTAAGACCCAAGTGGAGCAG
Mi1mx-TRAV12 ACACGACGCTCTTCCGATCTGGTTCCACGCCACTC
Mi1mx-TRAV13 ACACGACGCTCTTCCGATCTTCCTTGGTTCTGCAGG
Mi1mx-TRAV14 ACACGACGCTCTTCCGATCTGCAGCAGGTGAGACAAAG 
Mi1mx-TRAV15 ACACGACGCTCTTCCGATCTCASCTTYTTAGTGGAGAGATGG
Mi1mx-TRAV16 ACACGACGCTCTTCCGATCTGTACAAGCAAACAGCAAGTG
Mi1mx-TRAV17 ACACGACGCTCTTCCGATCTCAGTCCGTGGACCAGC
Mi1mx-TRAV18 ACACGACGCTCTTCCGATCTAACGGCTGGAGCAGAG
Mi1mx-TRAV19 ACACGACGCTCTTCCGATCTGCAAGTTAAACAAAGCTCTCC
Mi1mx-TRAV21 ACACGACGCTCTTCCGATCTGTGCACTTGCCTTGTAGC
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Table 3.1 TRAV Multiplex primer sequences. 
In the first step PCR, a combination of TRAV-specific forward primers and a common extension 
sequence 5’-ACACGACGCTCTTCCGATCT-3’ at an equimolar ratio were used with a 
Cα-specific reverse primer 5’-TCAGCAGGAGGATTCGGAGTCCCA-3’. In the second step, a 
step-out PCR was performed using primers containing the MiSeq Universal Adapter sequences 
followed by a region overlapping that of the first PCR primers. The reverse primer also contains 
an 8 bp Hamming barcode.  
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Table 3.2 TRAV designation, CDR3 amino acid (a.a.) sequences, and in vitro bacterial 
reactivity of indicated TCR clones.  
TCR clone TRAV CDR3 a.a. sequence Isolate specificity
CT2 TRAV14-3*02 AASAIWNTGYQNFY H. typhlonius
CT6 TRAV14-3*01 AASGYSALGRLH H. apodemus & Unc Clostridium spp.
CT9 TRAV14-1*01 AASADNRAGNKLT H. typhloniu & H. apodemus
T7-1 TRAV7-4*01 AASGWGDSNYQLI H. typhlonius & H. apodemus
DP1 TRAV14-1*01 AASTSNNNAPR B. vulgatus & B. acidifaciens
NT2 TRAV14D-3 AARSGRSSALGRLHF B. acidifaciens & B. uniformis
CT7 TRAV14D-1*01 AASATGDNRIF B. uniformis
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Chapter 4: Concluding Remarks and Future 
Directions 
 
Development of tolerance to Helicobacter species 
Our data showed that Helicobacter spp. increased the frequency of colonic Treg cells 
(Figure 2.6). This is potentially due to conversion of naïve T cells to Treg cells in the colon 
draining LNs after bacterial antigen encounter, as indicated by Tg cell studies (Figure 2.1 and 
2.4). Therefore, the hosts develop tolerance to Helicobacter species. As Helicobacter species are 
known to induce gut pathology in several mice strains with immunodeficiency, we predict that 
pTreg induction by intestinal pathobionts could be involved in tolerance development in 
wild-type animal. A good model to test this is to use mice deficient in CNS1 which is essential 
for peripheral Treg cell selection24,25. It would be interesting to investigate whether T cell 
response to Helicobacter spp. might be skewed towards effector T cell generation in the CNS1-/- 
hosts, and thus render these mice more susceptible to colonic inflammatory models.  
It remains unclear how intestinal APCs interact with bacteria to facilitate pTreg induction. 
Previous studies suggest that CD103+ DCs can favor Treg cell selection through the production 
of RA and TGFβ18,82,83,86. Yet a recent study showed a specific increase in the IL-10high 
MHCII+CD11b+CD11cint/highCD64+ resident macrophages after H. hepaticus colonization176. H. 
hepaticus also triggers an anti-inflammatory gene signature in intestinal macrophages through 
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production of soluble polysaccharide that activates TLR2. As H. hepaticus induces IL-23-driven 
pathology in the absence of IL-10156, it is reasonable to hypothesize that IL-10 production by 
macrophages could be essential for tolerance development. We will interrogate this question 
further with available genetic APC mouse tools coupled with Tg cell transfer.  
Besides direct antigen presentation, gut bacteria can also influence CD4 T cells through 
the production of metabolites. One classic example is bacteria-derived SCFAs, which have been 
linked to enhanced Treg expansion92. As metabolites exert broad antigen-independent effect, it is 
possible that Treg induction by Helicobacter spp. could be influenced by metabolites derived 
from the whole microbiome. Testing our Tg model in GF setting or in hosts with different 
microbiota will be informative to address this question.  
 
Bacteria contributing to Teff responses during colitis  
Our data from both the Tg adoptive transfer study as well as TCR repertoire analysis 
(Figure 3.1 and 3.3) indicate that Teff cells share TCRs with Treg cells during colitis, hence, 
pTreg response to gut bacteria could be diverted to Teff generation. This phenomenon argues that 
tolerogenic bacteria also contribute to intestinal inflammation during the pathogenesis of IBD. 
As we focused on Helicobacter spp. in our study which are known for immune-stimulatory 
functions, a more global analysis interrogating the effect of other bacterial species are needed. 
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Understanding how different microbes play a role in IBD will improve our knowledge of the 
disease, and thus development of more targeted therapies.  
We tried to address this question based on geographic locations of gut microbes in our 
study. We noticed a large bloom of Bacteroides spp. in the lumen in our colitis model, yet these 
species failed to elicit antigen-specific Teff activation. This is contrary to Helicobacter spp. that 
reside deeply in the mucus layer, and are potent stimulus for Teff cells under inflammatory 
condition. Although it is too early to form generalized ideas, our data provide evidence that even 
in the setting of barrier dysfunction, T cell responses could still be specifically targeted, 
indicating a different layer of immune-regulation during inflammation. Future studies are needed 
to clarify how immune system are regulated to respond to different microbes in colitis.   
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